Osmotic demyelination syndromes …

Douglas J Lanska MD MS MSPH

General Neurology

Updated 05.08.2024
Released 04.14.2003
Expires For CME 05.08.2027

Osmotic demyelination syndromes

Author: Douglas J Lanska MD MS MSPH

See Contributor Disclosures

Osmotic demyelination syndromes

In This Article

Quick Link

Introduction

Overview

Spastic quadriparesis, pseudobulbar palsy, and pseudobulbar affect occurring several days following a rapid rise in serum osmolality are the classical signs of osmotic demyelination syndrome. The author reviews the classic clinical signs and pathophysiology of osmotic demyelination syndrome and includes updates from literature on methods of prevention and potential future treatment options for this infrequent but preventable iatrogenic disease.

Key points

	• All patients with severe hyponatremia receiving intravenous fluids should have serum sodium measured every 4 hours to allow for adjustments in fluid and electrolyte administration if serum sodium should rise at a rate greater than 0.5 mEq/ml per hour.
	• Use of desmopressin to limit water diuresis during correction of severe hyponatremia should be considered to prevent overcorrection.
	• Vaptans are efficacious and safe in treating hypervolemic and normovolemic hyponatremia.
	• Because patients with severe hyponatremia and concomitant hypokalemia are at greater risk of developing osmotic demyelination syndrome, a slower correction than 12 mEq/ml in a 24-hour period should be considered.
	• Treatment of osmotic demyelination syndrome is mainly supportive; no large clinical trials have been performed to examine the efficacy of therapeutic relowering of serum sodium, steroids, plasma exchange, or IVIG.

Historical note and terminology

The factors that led to the appearance of osmotic demyelination syndrome during the 1950s were the introduction of diuretics, the liberal use of intravenous fluids, and the ability to rapidly measure serum electrolytes (151).

The original description of osmotic demyelination syndrome was by Raymond Adams (1911-2008), Maurice Victor (1920-2001), and Elliott Mancall (1927-2013) in 1959 (02). During their studies of the neuropathology of alcoholism, they recognized a peculiar and unique pattern of demyelination occurring in the central pons of four individuals with alcoholism and malnutrition. They labeled this disorder “central pontine myelinolysis.”

The initial suggestion that an “electrolyte imbalance may be a contributing factor” in the development of central pontine myelinolysis was made by Canadian neuropathologist Kenneth Berry (1932-2006) and Polish-Canadian neuropathologist Jerzy Olszewski (1913-1964) (22).

In 1969, American internist Alfredo Paguirigan and American neurologist Edward B Lefken noted that acute cases of central pontine myelinolysis only developed in hospitalized patients who were being hydrated (142).

American neuropathologists Kevin O Leslie and Michael D Norenberg, along with British-American neurologist Andrew S Robertson (106; 136) noted that in 12 cases of acute central pontine myelinolysis, there had been a recent rapid rise of serum sodium in each patient; they suggested that central pontine myelinolysis “is an iatrogenic disorder that in most cases is caused by a rapid correction of serum sodium rather than by hyponatremia per se.”

Subsequently, demyelination in other areas of the central nervous system associated with osmotic stress has been described (ie, extrapontine myelinolysis), encouraging the use of the more general term “osmotic demyelination syndrome” rather than the more restrictive term “central pontine myelinolysis” (151; 117). In addition, osmotic demyelination has been observed with other electrolyte disorders, including hypernatremia, hypokalemia, hypophosphatemia, and hyperammonemia, as well as the hyperosmolar hyperglycemic state.

Clinical manifestations

Presentation and course

	• Osmotic demyelination develops several days after a rapid rise in serum sodium (characteristically, but not exclusively, greater than 12 mEq/ml in a 24-hour period).
	• Cases of osmotic demyelination have been described with slower rates of correction of serum sodium and, rarely, with correction of hypernatremia.
	• The classical clinical presentation of central pontine myelinolysis includes progressive spastic quadriparesis, pseudobulbar palsy, and pseudobulbar affect.
	• The clinical features of extrapontine myelinolysis vary depending on the location of the lesions and may include altered mental status, emotional lability, akinetic mutism, gait disturbance, and myoclonus.

Hyponatremic osmotic demyelination. The clinical syndrome of osmotic demyelination develops in hospitalized patients several days after a rapid rise in serum sodium (characteristically greater than 12 mEq/ml in a 24-hour period, although cases have been described with slower rates of correction).

Prior to the onset of osmotic demyelination, patients may present with the neurologic signs and symptoms of hyponatremic encephalopathy. These symptoms resolve with normalization of the serum sodium concentration. Three to 5 days later, a second phase of neurologic manifestations occurs with the onset of myelinolysis. The clinical features vary, depending on whether the syndrome consists of central pontine myelinolysis, extrapontine myelinolysis, or both. Occasional cases are identified incidentally by neuroimaging obtained for other reasons (205).

The classical clinical presentation of central pontine myelinolysis includes progressive spastic quadriparesis, pseudobulbar palsy, and pseudobulbar affect (151). Severe outcomes include the “locked-in” syndrome and death (101).

Central pontine myelinolysis patient (1)

Patient with central pontine myelinolysis with pseudobulbar palsy (note protruded tongue) and spastic quadriparesis (note spastic posturing of arms). (Contributed by Dr. Jack Riggs.)
Central pontine myelinolysis patient (2)

Patient with central pontine myelinolysis demonstrating pseudobulbar affect. She was asked, “Do you ever feel sad?” This question was sufficient to evoke this response, demonstrating the emotional lability characteristic of pseudo...

Other symptoms may include lethargy, dysarthria, dysphagia, ophthalmoplegia, ataxia, nystagmus, oculomotor nerve palsy (128; 70), and various movement disorders, particularly parkinsonism and dystonia (160; 170; 10; 102).

Extrapontine myelinolysis. Extrapontine myelinolysis often affects the thalamus and basal ganglia. The clinical features of extrapontine myelinolysis vary depending on the location of the lesions and may include altered mental status, emotional lability, akinetic mutism, gait disturbance, and myoclonus. Movement disorders, including parkinsonism, dystonia, and other extrapyramidal signs, have been described (45; 47). Although not commonly affected by osmotic demyelination syndrome, the spinal cord has also been recognized as a site of extrapontine myelinolysis (78). These manifestations may occur with or without features of central pontine myelinolysis and may also occur in the same time frame (48).

Hyponatremic osmotic demyelination (1)

T2-weighted MRI in a 41-year-old woman who presented with acute parkinsonism following slow correction of hyponatremia resulting from repeated vomiting. MRI showed symmetrical hyperintensities in caudate nuclei (small, thin, bl...
Hyponatremic osmotic demyelination (2)

T2-weighted FLAIR in a 41-year-old woman who presented with acute parkinsonism following slow correction of hyponatremia resulting from repeated vomiting. Images showed bilaterally symmetrical hyperintensities in the caudate nu...
Hyponatremic osmotic demyelination (3)

T2-weighted MRI in a 41-year-old woman who presented with acute parkinsonism following slow correction of hyponatremia resulting from repeated vomiting. MRI of the pons showed no abnormality. (Source: Sajith J, Ditchfield A, Ka...
Hyponatremic osmotic demyelination (4)

T2-weighted MRI in a 41-year-old woman who presented with acute parkinsonism following slow correction of hyponatremia resulting from repeated vomiting, and whose initial MRI was consistent with extrapontine myelinolysis. MRI a...

Hypernatremic osmotic demyelination. Severe postpartum hypernatremia may present as an encephalopathy with rhabdomyolysis and diffuse white matter hyperintensities on MRI compatible with osmotic demyelination (131; 163; 24; 146; 11; 36; 186; 38; 84). Other causes of severe hypernatremia have also been associated with osmotic demyelination syndrome (see "Etiology and pathogenesis" section).

Prognosis and complications

The prognosis of osmotic demyelination syndrome is variable and probably depends on the size and severity of the demyelination in the central pons. Some affected individuals develop only subclinical lesions in the pons that are later noted on an MRI obtained for other reasons or are noted as an incidental finding on autopsy. Some patients with extremely severe quadriparesis and inability to speak or swallow can make an essentially complete neurologic recovery over the course of weeks or months, whereas other similarly affected patients may have virtually no improvement. Aspiration and other complications associated with being paralyzed (eg, deep venous thrombosis and decubitus ulcers) are among the frequent complications of osmotic demyelination syndrome.

One study of 25 patients with osmotic demyelination syndrome found that 46% had a favorable outcome at follow-up 2 years after diagnosis. Predictors of poor outcome were severe hyponatremia (< 115 mEq/L), hypokalemia, low Glasgow Coma Scale scores at presentation, and poor functional independence measure scores during hospitalization (85). A review of 38 case series comprising a total of 541 patients revealed that liver transplant patients with osmotic demyelination syndrome have a combined rate of death and disability of 77%, compared with 45% in those without liver transplantation (P< 0.001) (171).

Diffusion tensor imaging may help clarify the prognosis for functional improvement following osmotic demyelination (104).

Clinical vignette

Case 1: Osmotic demyelination syndrome after correction of severe hyponatremia and hypokalemia in hyperemesis gravidarum (39). A 21-year-old woman was hospitalized for severe hyperemesis in the 10th week of gestation. At admission, she was restless and confused, with severe hyponatremia (serum sodium 107 mmol/L) and hypokalemia (serum potassium 1.1 mmol/L). Active and simultaneous correction of these imbalances caused an overly rapid increase in serum sodium levels (10 mmol/L in the first 6 hours and 17 mmol/L in the first 24 hours).

Osmotic demyelination syndrome after correction of severe hyponatremia and hypokalemia in hyperemesis gravidarum (1)

Serial serum concentrations of sodium [Na+] and potassium [K+] during active treatment for correction of severe hyponatremia and hypokalemia. (Source: Corona G, Simonetti L, Giuliani C, Sforza A, Peri A. A case of osmotic demye...

The isotonic saline solution was stopped and replaced by 5% dextrose solution infusion. However, her neurologic abnormalities worsened with the development of hypotonia, tremor, and involuntary muscle spasms.

The pons appeared normal on T2-weighted, FLAIR, and T1-weighted images. However, brain MRI revealed bilateral increased signal intensity of the lenticular nuclei, claustrum, and caudate nuclei on axial T2-weighted and FLAIR images. The T1-weighted images showed moderate hypointensity in the same nuclei.

Osmotic demyelination syndrome after correction of severe hyponatremia and hypokalemia in hyperemesis gravidarum (2)

Bilateral increased signal intensity of the lenticular, claustrum, and caudate cerebral nuclei on an axial T2-weighted image. (Source: Corona G, Simonetti L, Giuliani C, Sforza A, Peri A. A case of osmotic demyelination syndrom...
Osmotic demyelination syndrome after correction of severe hyponatremia and hypokalemia in hyperemesis gravidarum (3)

Bilateral increased signal intensity of the lenticular, claustrum, and caudate cerebral nuclei on an axial FLAIR image. (Source: Corona G, Simonetti L, Giuliani C, Sforza A, Peri A. A case of osmotic demyelination syndrome occu...
Osmotic demyelination syndrome after correction of severe hyponatremia and hypokalemia in hyperemesis gravidarum (4)

Moderate hypointensity of the lenticular, claustrum, and caudate cerebral nuclei on an axial T1-weighted image. (Source: Corona G, Simonetti L, Giuliani C, Sforza A, Peri A. A case of osmotic demyelination syndrome occurred aft...

These foci did not enhance with Gd-DTPA. The radiological features were consistent with the diagnosis of extrapontine osmotic demyelination syndrome.

Intravenous steroid administration was followed by progressive improvement of biochemical and clinical abnormalities. At discharge 20 days later, she could eat and walk with minimal external support. The patient delivered a healthy boy at 36 weeks of gestation by cesarean section, and at the 4-month follow-up evaluation, the child appeared to be healthy. Unfortunately, even with physical therapy, the mother achieved only mild improvement in her neurologic deficits.

Case 2: Development of parkinsonism in a patient with central pontine myelinolysis (10). A 69-year-old man with a long personal history of type II diabetes, hypertension, hypercholesterolemia, peripheral arterial obstruction, and depression had worked with glues and cement for about 40 years. He had no family history of neurologic diseases. In 2007, he was referred for evaluation of a 10-year history of severe daily headaches described as an “increasingly strange sensation of pain in the head." His medication history included clomipramine (for about 10 years), fluoxetine, several benzodiazepines (lorazepam, delorazepam, oxazepam), and olanzapine (for about 1 year). Cognitive function, cranial nerves, and upper and lower limb function were normal. Brain MRI disclosed a pontine lesion compatible with central pontine myelinolysis as well as multifocal cerebral ischemic lesions, attributable to his long history of hypertension and type II diabetes.

Pontine lesion compatible with central pontine myelinolysis (MRI)

MRI fluid-attenuated inversion recovery (FLAIR) in 2007 (a, c) and in 2014 (b, d). Over this 7-year period, there was a reduction in the apparent volume of central pontine myelinolysis (a, b); the hyperintensities in deep white...

At age 71, asymmetric signs of parkinsonism (left-sided rigidity and bradykinesia) were noted during clinical evaluation. Levodopa/carbidopa was started, and the symptoms improved. A DaT-Scan SPECT revealed a moderate asymmetric reduction of pre-synaptic dopamine transporters in the right striatum.

Asymmetric reduction of dopamine transporters in central pontine myelinolysis (SPECT)

DaT-scan SPECT showing asymmetric reduction of dopamine transporters in right striatum. (Source: Antonioni A, Rispoli V, Fazio P, Golfrè Andreasi N, Govoni V, Granieri E. Development of Parkinsonism in a patient with central po...

The symptoms slowly worsened, and when the patient was last evaluated in 2019, the neurologic assessment showed hypomimia with stuttering and mild-moderate bilateral bradykinesia and rigidity, both more prominent on the left side. No rest tremor was present. He could only stand up from a chair with the help of his arms. His posture was moderately stooped without postural reflex impairment. His left foot did not clear the floor while walking. He had no sensory disturbances. He remained independent in activities of daily living and was almost independent in instrumental activities of daily living. He did not complain of daytime sleepiness, and a polysomnographic investigation showed no evidence of REM sleep behavioral disorder. Myocardial scintigraphy (123I-MIBG) was normal, with no evidence of cardiac adrenergic denervation. Satisfactory motor symptom control was achieved with low-dose levodopa/carbidopa.

Case 3: Osmotic demyelination syndrome in an alcoholic patient with rest tremor (06). A 49-year-old woman presented to an emergency department with 3 days of confusion, dysarthria, tremor, and imbalance. She had been discharged 6 days earlier from another hospital after an admission for alcohol withdrawal. She had returned to that facility twice the following week, complaining of progressive incoordination and weakness. Her husband had reported needing to carry her around the house. She denied alcohol consumption since her previous hospitalization.

Her examination was significant for horizontal gaze-evoked nystagmus, mild dysarthria, a resting tremor of both arms, and ataxia with heel-to-shin testing.

Post-contrast MRI of the brain showed enhancement of the pons with sparing of the corticospinal tracts and peripheral pontine fibers. These imaging findings have been described as a “trident sign” or “pig snout” due to their characteristic shape (86).

Osmotic demyelination syndrome in alcoholic patient with rest tremor

T1 post-contrast MRI showing demyelination (A) of the pons, sparing the corticospinal tracts (asterisks) and peripheral pontine fibers (arrows). This pattern has been likened to a trident (B) or pig snout (not shown). (Source: ...

Case 4: Osmotic demyelination syndrome after transcatheter aortic valve replacement (TAVR) (83). A 64-year-old woman was admitted with a 2-month history of chest tightness, dyspnea, and fatigue, which had worsened in the 3 days prior to presentation. Auscultation revealed crackles in the lung fields, and systolic murmurs could be easily heard in the aortic area. Chest x-ray showed pulmonary edema, and transthoracic echocardiography showed severe aortic stenosis.

Osmotic demyelination syndrome after transcatheter aortic valve replacement (chest x-ray)

Chest x-ray on admission showed pulmonary edema and bilateral pleural effusions (A). After transcatheter aortic valve replacement, chest x-ray showed that the pulmonary edema and bilateral pleural effusions had decreased (B). (...

Her serum sodium was 135 mmol/L. Despite a diuretic, her symptoms worsened. She became hypotensive and unresponsive to dobutamine, prompting an emergency TAVR with extracorporeal membrane oxygenation support. Postoperatively, her urine output increased markedly, and serum sodium increased sharply from 140 to 172 mmol/L.

Serial serum sodium concentrations before and after transcatheter aortic valve replacement

Note that the dates on the x-axis are given in the format DD/MM. (Source: Jin X, Wang Y. Case report: osmotic demyelination syndrome after transcatheter aortic valve replacement: case report and review of current literature. Fr...

Because she remained unconscious, two CT scans were performed but these were unrevealing. MRI showed multiple lesions in the pons suggestive of osmotic demyelination syndrome.

Osmotic demyelination syndrome after transcatheter aortic valve replacement (head CT)

Head CT scans didn’t demonstrate any abnormality, including hypodensity in the pons, on either 1 day post-op (A) or 7 days post-op (B). (Source: Jin X, Wang Y. Case report: osmotic demyelination syndrome after transcatheter aor...
Osmotic demyelination syndrome after transcatheter aortic valve replacement (MRI)

Axial T1-weighted MRI demonstrated symmetric low signal in the central pons (A, E). Axial T2-weighted MRI demonstrated a symmetric high signal in the central pons (B, F). T2 FLAIR images demonstrated a symmetric high signal in ...

Case 5: Stuttering subacute onset of osmotic demyelination syndrome confused with motor neuron disease and cerebrovascular disease (141). A 48-year-old man with no prior history of diabetes presented with complaints of generalized limb weakness and incoordination of about 1-month duration. No focal neurologic deficit was identified on examination, but his laboratory studies revealed a severely elevated blood glucose of 608 mg/dL with HgbA1c of 14.7%, a corrected sodium level of 133 mmol/L, and normal serum potassium of 3.8 mmol/L (141). T2-weighted MRI showed pontine hyperintensities on the initial imaging.

Pontine hyperintensities in man with stuttering subacute onset of osmotic demyelination syndrome (MRI)

In this 48-year-old man with the stuttering progression of neurologic deficits over several months, the initial T2-weighted MR imaging showed pontine hyperintensities (thin red arrows). (Source: Olowoporoku IG, Digala LP, Attel...

His hyperglycemia was treated, and he was discharged home on an oral hypoglycemic agent, but he was not compliant with this medication.

He was lost to follow-up until 2 months later when he again presented to an emergency room. He complained of several months of progressive symmetric generalized limb weakness, with a 1-month history of slurred speech, labile emotions, and uncontrollable laughter. Examination disclosed pseudobulbar palsy, quadriparesis, diffuse hyperreflexia, fasciculations in the right lower extremity, extensor plantar response, ataxia, and decreased vibration in the legs. He was wheelchair-bound. Laboratory data revealed hyperglycemia (serum glucose 391 mg/dL with HgbA1c 12.4%), normal serum sodium (136 mmol/L), and normal serum potassium (3.7 mmol/L). The initial working diagnosis was motor neuron disease because of the upper and lower motor neuron signs, but electromyography was inconsistent with this and instead showed a mild predominant sensory axonal length-dependent polyneuropathy. MRI of the brain showed an area of worsening signal hyperintensity in the central pons on T2-weighted and FLAIR sequences.

Worsening pontine hyperintensities on follow-up in osmotic demyelination syndrome (MRI)

In this 48-year-old man with the stuttering progression of neurologic deficits over several months, the follow-up T2-weighted image showed worsening pontine hyperintensities (thin red arrows). (Source: Olowoporoku IG, Digala LP...
Pontine hyperintensities in man with stuttering subacute onset of osmotic demyelination syndrome (FLAIR)

In this 48-year-old man with the stuttering progression of neurologic deficits over several months, the follow-up FLAIR sequence showed pontine hyperintensities (thick red arrows). (Source: Olowoporoku IG, Digala LP, Attele DP....

There was also restricted diffusion in the central pons on diffusion-weighted imaging with no apparent diffusion coefficient correlation. A subacute brainstem stroke was considered, but the pattern and central location of the pontine lesion with no apparent diffusion correlate were against a vascular etiology. With the central pontine location of the signal abnormalities and the specific imaging characteristics (T2-weighted signal intensity with restricted diffusion on DWI), he was diagnosed with central pontine myelinolysis.

Although he clinically improved with treatment of his hyperglycemia, his ataxia persisted. He was discharged to inpatient rehabilitation. At a follow-up clinic visit, he could ambulate unassisted, and his HgbA1c was 7%.

Case 6: Postpartum hypernatremia with extrapontine myelinolysis and rhabdomyolysis (38). A 29-year-old postpartum woman, G2P1A0, was brought to the emergency department in an unconscious state after a 4- or 5-day history of fever and decreased urine output. Nine days before this, she had an apparently uncomplicated full-term vaginal delivery. On examination, she had a fever of 104.6F (40.3C) and was tachycardic (144 beats per minute) but was normotensive (100/68 mmHg) without any vasopressors. She had no nuchal rigidity. Her Glasgow Coma Scale score was 7 (E2V1M4). She responded to painful stimuli by opening her eyes (without a verbal response) and normally flexing her limbs. Her pupils were equal and reactive to light. Plantar response was flexor. Based on her GCS score, she was intubated and placed on mechanical ventilation. Her provisional diagnosis was meningoencephalitis, so she was started on ceftriaxone 2 g intravenously twice a day.

CT of the brain was normal.

Extrapontine myelinolysis and rhabdomyolysis (CT)

Noncontrast computed tomography of the head at the level of the basal ganglia (a) and centrum semiovale (b) showed no evident abnormalities. (Source: Choudhary G, Qureshi F, Arora A, Kothari N, Tiwari S, Bhatia P. Postpartum hy...

Laboratory studies showed severe hypernatremia (serum sodium 182meq/L), plasma hyperosmolality (439 mOsmol/kg, with normal values typically from 275 to 295 mOsm/kg), normal urine osmolality (782 mOsmol/kg), leukocytosis (total white blood cell count 16,680/mL), azotemia (blood urea nitrogen 171 mg/dL; serum creatinine 2.56 mg/ dL), and rhabdomyolysis (serum creatinine phosphokinase 475 IU; serum lactate dehydrogenase 1229 IU/L; urine myoglobin 1200 ng/mL). CSF biochemical studies and cell counts were normal. All cultures were sterile.

Intravenous administration of balanced crystalloids was started. A nasogastric tube was inserted, and free water replacement was started because the total free water deficit was calculated to be approximately 7.8 L. Serial monitoring of serum sodium was conducted using arterial blood gas analysis.

Change in serum sodium concentration in extrapontine myelinolysis and rhabdomyolysis

Change in serum sodium concentration (mEq/L) over more than 5 days (D). Note that the x-axis is not strictly linear, so the time-intervals are not uniform across all of the days. (Source: Choudhary G, Qureshi F, Arora A, Kothar...

The rate of sodium correction was kept below 1 mEq/L/h. Over the next days, her serum sodium level dropped to 142 mEq/L. Sedation was stopped, and weaning trials were attempted. She could follow verbal commands by opening and closing her eyes and could identify her relatives by nodding her head. However, she was nearly quadriplegic, with muscle power between 1/5 to 2/5 in all four limbs.

MRI of the brain and spine revealed abnormal hyperintense signals involving the middle cerebellar peduncles, splenium of the corpus callosum, and posterior limb of the internal capsule.

Extrapontine myelinolysis and rhabdomyolysis (brain MRI and FLAIR)

Axial T2 images (a, b) show abnormal hyperintense signal involving the middle cerebellar peduncles, splenium of the corpus callosum, and posterior limb of the internal capsule. The coronal fluid-attenuated inversion recovery (F...

FLAIR images revealed hyperintense signal and restricted diffusion along the corticospinal tract involving the centrum semiovale, corona radiata, posterior limb of the internal capsule, and crus cerebri, giving a "wine-glass" appearance on coronal images. Symmetrical signal changes also involved the middle cerebellar peduncles and the splenium of the corpus callosum. Gradient images showed microhemorrhages in the involved region.

The final diagnosis was postpartum hypernatremic encephalopathy with osmotic extrapontine myelinolysis and rhabdomyolysis (“rhabdomyelinolysis”).

Considering the bulbar involvement, she could not be readily extubated, so percutaneous tracheostomy was performed on day 12. She was then weaned from the ventilator. As she could not swallow semisolids, a percutaneous endoscopic gastrostomy was performed for long-term feeding.

She gradually improved while still in the intensive care unit. By the time of discharge to rehabilitation, she could sit with support, and her muscle power improved to grade 3/5 in the arms and grade 2/5 in the legs.

Biological basis

	• Osmotic demyelination syndrome is most closely linked to rapid correction of chronic hyponatremia.
	• Not all (or even a large proportion of) patients with a rapid increase of their serum sodium develop osmotic demyelination syndrome; consequently, other factors may be important, including other electrolytes (particularly potassium, but also magnesium and phosphate).
	• Central pontine myelinolysis has been reported despite slow correction of hyponatremia.
	• Patients undergoing liver transplantation are particularly vulnerable to developing osmotic demyelination syndrome.

Etiology and pathogenesis

Central pontine myelinolysis with rapid correction of hyponatremia. Central pontine myelinolysis is commonly associated with rapid correction of chronic hyponatremia but has been reported despite appropriate or even slow correction of hyponatremia (105; 116; 79; 164; 192; 150). Rapid correction of hyponatremia exerts its effects by causing an osmotic shift and not because of any specific property of the sodium ion per se (120).

Neurologic complications were noted in eight patients whose serum sodium had been corrected by more than 12 mEq/liter per day (182). Conversely, uncomplicated recoveries were noted in patients in whom hyponatremia was corrected more slowly than by 12 mEq/liter per day. In a literature review of 80 patients with severe hyponatremia (serum sodium < 106 mEq/liter), enough detail was reported in 51 patients to determine a maximal rate of correction of serum sodium. In 39 of 51 patients who were corrected rapidly (more than 12 mEq/liter per day), 22 (58%) had some neurologic complication (182). Of these 22 patients with neurologic complications, 14 (64%) were suspected of having central pontine myelinolysis. None of the 13 patients who were corrected slowly (< 12 mEq/liter per day) experienced a neurologic complication. Prospective MRI studies have also demonstrated the development of characteristic pontine lesions in patients treated for hyponatremia in whom the rate of correction of the hyponatremia was rapid (29).

Other causes and contributing factors for osmotic demyelination. Not all (or even a large proportion of) patients with a rapid increase in serum sodium develop osmotic demyelination syndrome. Consequently, other etiologic factors are operative.

Hypokalemia. Hypokalemia appears to significantly impact the likelihood of developing osmotic demyelination syndrome (112; 108; 21; 43; 123; 155). In a study of published reports of patients with central pontine myelinolysis in whom initial values of sodium and potassium were given, all patients who developed central pontine myelinolysis were initially hypokalemic (112). In some cases, hypokalemia may contribute to the development of osmotic demyelination syndrome by overcorrection of concomitant hyponatremia caused by potassium repletion without adequate free water replacement (21).

Other electrolyte disorders. Hypomagnesemia (155), parenteral magnesium administration (152), hypophosphatemia (196; 155), hyperammonemia (157; 191; 143), diabetic ketoacidosis (173), and hypernatremia (120; 131; 163; 24; 67; 146; 11; 36; 186; 81; 144; 145; 94; 103; 198; 38; 52; 84), particularly the rapid development of hypernatremia (120; 83), may also contribute to the risk of developing osmotic demyelination syndrome.

Osmotic demyelination syndrome occurred in a normonatremic 66-year-old woman after she developed severe hypomagnesemia (with additional hypokalemia and hypophosphatemia) following treatment with ciprofloxacin and metronidazole for gastroenteritis while on chronic proton pump inhibitor therapy with omeprazole (155). She presented with dizziness, vomiting, asthenia, and gait instability and subsequently had a generalized tonic-clonic seizure. Magnesium sulfate was administered in infusion and was withdrawn 2 days later. MRI showed age-related white matter changes and a pontine lesion (8 x 20 x 16 mm) consistent with osmotic demyelination: this lesion was hyperintense in T2-weighted and FLAIR sequences and hypointense in T1-weighted sequences, without diffusion restriction or enhancement after contrast administration. A CT body scan showed persistent diffuse thickening of the walls of the gastric fundus. Endoscopy showed mild chronic gastritis.

Hypointense central pons lesion in hypomagnesemia (axial T2 MRI)

Axial T2-weighted MRI sequence showing a hyperintense lesion in the central pons in a normonatremic woman with severe hypomagnesemia. (Source: Romero Calvo L, Garcia-Blanco MJ, Valenzuela F, Álvarez Granda J. Osmotic demyelinat...
Hypointense central pons lesion in hypomagnesemia (coronal T2 MRI)

Coronal T2-weighted MRI sequence showing a hyperintense lesion in the central pons in a normonatremic woman with severe hypomagnesemia. (Source: Romero Calvo L, Garcia-Blanco MJ, Valenzuela F, Álvarez Granda J. Osmotic demyelin...
Hypointense central pons lesion in hypomagnesemia (axial FLAIR MRI)

Axial FLAIR MRI sequence showing a hyperintense lesion in the central pons in a normonatremic woman with severe hypomagnesemia. (Source: Romero Calvo L, Garcia-Blanco MJ, Valenzuela F, Álvarez Granda J. Osmotic demyelination sy...
Hypointense central pons lesion in hypomagnesemia (axial T1 MRI)

Axial T1-weighted MRI sequence showing a hypointense lesion in the central pons in a normonatremic woman with severe hypomagnesemia. (Source: Romero Calvo L, Garcia-Blanco MJ, Valenzuela F, Álvarez Granda J. Osmotic demyelinati...
Gastric wall thickening (abdominal CT)

Subsequent endoscopy showed chronic gastritis. (Source: Romero Calvo L, Garcia-Blanco MJ, Valenzuela F, Álvarez Granda J. Osmotic demyelination syndrome in a normonatremic patient under treatment with proton pump inhibitors. Cu...

Hyperosmolar hyperglycemic state. The hyperosmolar hyperglycemic state has been studied extensively (66; 71; 99; 88; 122; 35; 141; 206; 80; 124; 129; 149; 167; 185).

A case of central pontine myelinolysis due to hyperosmolar hyperglycemia was reported by Qu and colleagues (149). A previously healthy 46-year-old man presented with limb weakness and dysarthria for 20 days. There was no history of diabetes or alcohol abuse. Examination showed mild dysarthria, normal muscle tone, severe bilateral limb weakness (MRC grade 2–3 in all limbs), mildly decreased muscle stretch reflexes, flexor plantar responses, and normal sensation. Blood glucose was 49.7 mmol/L (894.6 mg/dL; reference range of 4–7 mmol/L), with hemoglobin A1c 16.3%, beta-hydroxybutyric acid 0.5 mmol/L, and 1+ ketones in his urine. His serum sodium was mildly low at 128 mmoL/L (128 mEq/L; reference range 133–146 mmol/L), but his serum potassium was moderately low at 2.8 mmol/L (2.8 mEq/L; reference range of 3.5–5.0 mmol/L). Calculated serum osmolality was 325 mosm/kg. Normal saline (0.9% NaCl) and insulin therapy (0.1 U/kg/h) were started. His blood glucose level declined rapidly. MRI demonstrated areas of hypointense signal in the central pons on T1-weighted imaging and hyperintense signal in corresponding areas on diffusion-weighted imaging, T2-weighted imaging, and fluid attenuated inversion recovery (FLAIR) sequences, all consistent with central pontine myelinolysis. His blood glucose level was controlled with long-acting and short-acting insulin. In the following 6 months, his symptoms gradually improved, and muscle power returned to normal in his limbs. He gradually resumed his daily activities without residual symptoms.

Osmotic demyelination after rapid correction of hyperosmolar hyperglycemia (1)

Osmotic demyelination in a 52-year-old woman after rapid correction of hyperosmolar hyperglycemia, axial diffusion-weighted imaging demonstrated restricted diffusion of the central pons (A and D) with correlate hypointense sign...
Osmotic demyelination after rapid correction of hyperosmolar hyperglycemia (2)

Osmotic demyelination in a 52-year-old woman after rapid correction of hyperosmolar hyperglycemia, axial diffusion-weighted imaging demonstrated restricted diffusion of the middle cerebellar peduncles (A) and correlate T2 FLAIR...
Serial blood glucose levels in 46-year-old man with hyperosmolar hyperglycemia and central pontine myelinolysis

(Source: Qu HL, Sun XY, Dai YJ. Central pontine myelinolysis: a rare finding in hyperosmolar hyperglycemia. Front Neurol 2023;14:1216328. Creative Commons Attribution 4.0 International [CC BY 4.0] license, creativecommons.org/l...
Central pons hypointense signal in central pontine myelinolysis and hyperosmolar hyperglycemia (axial T1 MRI)

Axial T1-weighted sequence showing hypointense signal in the central pons consistent with central pontine myelinolysis in a 46-year-old man with hyperosmolar hyperglycemia. (Source: Qu HL, Sun XY, Dai YJ. Central pontine myelin...
Central pons hyperintense signal in central pontine myelinolysis and hyperosmolar hyperglycemia (DWI)

Diffusion-weighted imaging (DWI) showing hyperintense signal in the central pons consistent with central pontine myelinolysis in a 46-year-old man with hyperosmolar hyperglycemia. (Source: Qu HL, Sun XY, Dai YJ. Central pontine...
Central pons hyperintense signal in central pontine myelinolysis and hyperosmolar hyperglycemia (axial T2 MRI)

Axial T2-weighted sequence showing hyperintense signal in the central pons consistent with central pontine myelinolysis in a 46-year-old man with hyperosmolar hyperglycemia. (Source: Qu HL, Sun XY, Dai YJ. Central pontine myeli...
Central pons hyperintense signal in central pontine myelinolysis and hyperosmolar hyperglycemia (axial FLAIR)

Axial FLAIR sequence showing hyperintense signal in the central pons consistent with central pontine myelinolysis in a 46-year-old man with hyperosmolar hyperglycemia. (Source: Qu HL, Sun XY, Dai YJ. Central pontine myelinolysi...

Alcoholism. Alcoholism has been the most commonly recognized etiologic factor for osmotic demyelination syndrome (02; 200; 134; 63; 69; 01; 128; 168; 61; 76; 44; 113; 158; 197; 07; 43; 135; 27; 50; 116; 119; 161; 34; 49; 51; 126; 20; 90; 111; 72; 04; 09; 79; 138; 148; 23; 53; 98; 103; 114; 140; 192; 42; 147; 62). The role of alcoholism as a risk factor for osmotic demyelination syndrome may derive from the frequent occurrence of hyponatremia with alcoholism, especially with beer potomania (110; 130).

Diabetes insipidus. There are four types of diabetes insipidus: (1) central diabetes insipidus is due to a lack of vasopressin (antidiuretic hormone) production (eg, due to injury to the hypothalamus or pituitary gland or genetics); (2) nephrogenic diabetes insipidus occurs when the kidneys do not respond properly to vasopressin; (3) dipsogenic diabetes insipidus results from excessive fluid intake (eg, due to damage to the hypothalamic thirst mechanism, certain medications, or psychiatric conditions, particularly schizophrenia, causing psychogenic polydipsia); (4) gestational diabetes insipidus, during late pregnancy and extending into the early postpartum period, is caused by excessive vasopressinase activity, an enzyme expressed by placental trophoblasts that metabolizes arginine vasopressin (118). Gestational diabetes insipidus usually develops in the third trimester and spontaneously remits 4 to 6 weeks postpartum.

Osmotic demyelination syndrome associated with diabetes insipidus has been reported with (1) accidental disruption of intranasal desmopressin treatment in patients with central diabetes insipidus after surgical treatment for a craniopharyngioma (26) or pituitary adenoma (209); (2) congenital nephrogenic diabetes insipidus presenting in infancy (93); and (3) transient postpartum diabetes insipidus (204).

Congenital nephrogenic diabetes insipidus presenting as osmotic demyelination syndrome in infancy (initial MRI)

Initial MRI on the third hospital day showed multifocal, symmetric lesions within the superior cerebellar peduncle, lateral pons, thalami, and posterior limb of internal capsule on T2-weighted images (T2WI) and diffusion-weight...
Congenital nephrogenic diabetes insipidus presenting as osmotic demyelination syndrome in infancy (follow-up MRI)

Follow-up MRI performed at 20 months of age showed symmetric high-signal-intensity changes in the superior cerebellar peduncle, lateral pons, thalami, and posterior limb of internal capsule on T2-weighted images (T2WI). (Source...

Hyperemesis gravidarum. Hyperemesis gravidarum presents various severe electrolyte disturbances that can be associated with osmotic demyelination syndrome (108; 187; 18; 39; 08), including hyponatremia (39), hypokalemia (108; 187), or both (18; 08). In this setting, osmotic demyelination may be accompanied by Wernicke encephalopathy (187; 18).

Burn patients. Burn patients are particularly vulnerable to developing osmotic demyelination syndrome (120). Burn patients who develop osmotic demyelination syndrome have had extreme serum hyperosmolality, whereas most burn patients without osmotic demyelination have not. Hypernatremia, hyperglycemia, and azotemia, alone or combined, accounted for the hyperosmolality. Hyponatremia was not present in any burn patient with osmotic demyelination syndrome.

Liver transplantation. Patients undergoing liver transplantation are particularly vulnerable to developing osmotic demyelination syndrome (41; 73; 52).

Postpartum hypernatremia. Severe postpartum hypernatremia may present as an encephalopathy with rhabdomyolysis and osmotic demyelination (131; 163; 24; 146; 11; 36; 186; 38; 84). Other causes of severe hypernatremia have also been associated with osmotic demyelination syndrome (67; 81; 144; 145; 94; 103; 198; 52), including frequent watery diarrhea in a patient treated with alternative medicine that included sodium chloride (67), a lactulose enema in a patient with chronic alcoholism (103), and extreme sodium intake in conjunction with restriction of fluid and food intake in an adolescent girl with an eating disorder (94).

Ethylene glycol poisoning. Rapid changes in serum osmolality from ethylene glycol poisoning and its treatment can cause osmotic demyelination syndrome, independent of changes in serum sodium levels (05).

Other proposed risk factors. Other proposed risk factors for osmotic demyelination syndrome include liver disease, malignancy, malnutrition, pregnancy or postpartum state, severe illness or sepsis, and adrenal insufficiency (166; 133; 59).

Pathology of osmotic demyelination. The pathological feature of osmotic demyelination syndrome is noninflammatory demyelination with relative sparing of neurons. This demyelination is most frequently seen in the central pons. Noninflammatory demyelination has also been described in other areas of the central nervous system where there is similarly an admixture of gray and white matter like that seen in the central pons (203; 65; 64). These extrapontine sites include the "hand knob area" of the bilateral precentral gyri; the splenium of the corpus callosum; external, extreme, and internal capsules; the basal ganglia; the lateral geniculate bodies; and the superior vermis of the cerebellum (172). Other areas of extrapontine myelinolysis include the cerebral peduncles and medullary pyramids (82).

Osmotic demyelination syndrome (macroscopic section of brain) (1)

Macrosection of pons from a patient with central pontine myelinolysis showing central area of demyelination. Preservation of myelin in pontine tegmentum (top portion) distinguishes this lesion from multiple sclerosis. Preservation...
Osmotic demyelination syndrome (macroscopic section of brain) (2)

Macrosection from a patient with osmotic demyelination syndrome showing small irregular area of demyelination in lateral geniculate body. (Contributed by Dr. Jack Riggs.)
Osmotic demyelination syndrome (macroscopic section of brain) (3)

Macrosection of basal ganglia from patient with osmotic demyelination syndrome showing demyelination of internal capsule (pale area to left) and demyelination of external and extreme capsules (pale areas to right). (Contributed by...

Pathophysiology of osmotic demyelination. Conventionally, rapid correction of chronic hyponatremia has been thought to cause glial swelling through osmosis, especially in the pons, eventually leading to myelinolysis and cell death. Unfortunately, because not all cases are readily explained by this mechanism, alternative pathophysiological explanations have been considered. For example, apoptosis has been considered an alternative pathophysiological mechanism, induced variously by osmotic stress, inadequate energy provision, and other factors (12).

Animal models of osmotic demyelination. Animal models of central pontine myelinolysis have been developed in the dog and rat (92). In both animals, demyelination follows rapid correction of sustained, vasopressin-induced hyponatremia with hypertonic saline (91; 100). Rapid correction of chronic hyponatremia is much more likely to result in myelinolysis than similar correction of acute or rapid hyponatremia (137). Disruption of the blood-brain barrier may be important in the pathogenesis of osmotic demyelination syndrome (165). The role of organic osmolytes and brain amino acids in chronic hyponatremia and osmotic demyelination syndrome has not been defined (194; 107).

Myelinolysis in animals may also be induced by rapid hypernatremia (176). Myelinolysis occurs in areas of the brain characterized by an extensive admixture and apposition of gray and white matter. The topography of oligodendrocytes may play a role; oligodendrocytes in vulnerable areas are predominantly located within adjacent gray matter, rather than within the white matter bundles. Because gray matter is much more vascular than white matter, oligodendrocytes in this location may be more vulnerable to serum osmotic shifts (153). Rapid correction of hyponatremia triggers apoptosis in astrocytes, followed by loss of trophic communication between astrocytes and oligodendrocytes, secondary inflammation, microglial activation, and demyelination (58). A study using the rat model suggested that osmotic stress may cause protein aggregation and ubiquitination and that demyelination may be a consequence of proteostasis failure (proteostasis, or protein homeostasis, is the process that regulates proteins within the cell to maintain the health of both the cellular proteome and the organism itself) (56).

Epidemiology

• In a 21st-century hospital series, inappropriately rapid correction of serum sodium (greater than 12 mmol/L over the first 24 hours) occurred in as many as 15% of patients, and 11% of those with too rapid correction developed osmotic demyelination.

Following its original description in 1959, many additional cases of central pontine myelinolysis were reported suggesting that osmotic demyelination syndrome was not a rare disorder. Moreover, it quickly became evident that not all cases of central pontine myelinolysis were associated with alcoholism or malnutrition, suggesting that osmotic demyelination syndrome could occur in any condition associated with rapid shifts in serum osmolality. A relatively high frequency of small “subclinical” lesions has been noted in pathological series (33; 64).

A study of 255 patients who presented to two large teaching hospitals between 2000 and 2007 with serum sodium <120 mmol/L found that inappropriately rapid correction of serum sodium (greater than 12 mmol/L over the first 24 hours) occurred in 37 patients (15%), with four patients developing osmotic demyelination (ie, 11% of those with inappropriately rapid correction) (197). Patients who developed osmotic demyelination were more likely to be younger, abuse alcohol (three of four patients), and have lower serum potassium levels.

A nationwide study in Sweden identified 83 individuals diagnosed with osmotic demyelination syndrome between 1997 and 2011 for an overall incidence of 0.61 per million person-years (04). Most cases were hyponatremic, with a medium sodium level of 104 mmol/L. All were chronically hyponatremic, and most were alcoholics. Patients with hyponatremia were treated mainly with isotonic saline and a minority with hypotonic fluids, with a median correction rate of 0.72 mmol/L/h; only six patients were corrected within the national treatment guidelines of less than or equal to 8 mmol/L/24h. At 3 months, most patients (60%) survived and became functionally independent, but 7% died.

Using hospital administrative records from a representative sample of US hospitals, osmotic demyelination syndrome was rare in a large cohort of 547,544 hospitalized patients with cirrhosis, with only 94 of these patients (0.02%) identified with the condition (23). In this cohort, alcohol-related cirrhosis, younger age, and female gender were associated with the disease.

In a single-center, retrospective chart review of 234 patients 18 years of age or older with at least one serum sodium <130 mEq/L during hospitalization, severe hyponatremia (serum sodium < 120 mEq/L) and history of alcohol use disorder were risk factors found to be associated with overcorrection of hyponatremia (147).

Prevention

	• Because rapid correction of chronic hyponatremia is more likely to produce osmotic demyelination syndrome, a judicious approach to the correction of chronic hyponatremia is strongly recommended.
	• There is no adequate justification for using hypertonic saline to treat asymptomatic or mildly symptomatic hyponatremia or to rapidly correct hyponatremia to levels above 120 to 125 mEq/liter in severe symptomatic hyponatremia.
	• Because patients with hyponatremia can rapidly correct even with normal saline, serum sodium should be measured every 4 hours to allow for fluid and electrolyte administration adjustments should serum sodium rise at a rate greater than 0.5 mEq/ml per hour.

Hyponatremic osmotic demyelination. In a single-center retrospective cohort study ("trohoc" study) of 50 patients admitted with initial serum sodium <125 mEq/L, overcorrection occurred in 14% (184); symptomatic hyponatremia at presentation and 3% saline were associated with overcorrection.

In a post hoc analysis of a multicenter, prospective randomized controlled study of 178 subjects with symptomatic hyponatremia (mean serum sodium level 118 mEq/L), overcorrection was defined as an increase in serum sodium level of more than 12 or 18 mEq/L within 24 and 48 hours, respectively (208). Twenty-one percent of the patients experienced hyponatremia overcorrection. Overcorrection was independently associated with initial severity of hyponatremia, chronic alcoholism, severe symptoms of hyponatremia, and severity of associated hypokalemia.

Because rapid correction of chronic hyponatremia is more likely to produce osmotic demyelination syndrome, a judicious approach to the correction of chronic hyponatremia is strongly recommended. There is no adequate justification for using hypertonic saline to treat relatively asymptomatic or mildly symptomatic hyponatremia or to rapidly correct hyponatremia to levels above 120 to 125 mEq/liter in severe symptomatic hyponatremia, but this continues to occur with devastating results for affected individuals (89). Hypertonic saline is reserved for patients with severe symptomatic hyponatremia; United States and European guidelines recommend treating severely symptomatic hyponatremia (ie, with signs of obtundation, coma, seizures, or cardiorespiratory distress) with bolus hypertonic saline to increase the serum sodium level by 4 to 6 mEq/L within 1 to 2 hours, but no more than 10 mEq/L within the first 24 hours; unfortunately, this approach exceeds the correction limit in 5% to 28% of patients (03).

In a 1993 review of 67 reported cases of osmotic demyelination syndrome since 1983, none documented by radiological studies or necropsy were treated with water restriction only (68). In a group of 27 hyponatremic patients treated only with water restriction and 35 with diuretic cessation alone, none developed osmotic demyelination syndrome. Consequently, water restriction or diuretic cessation may be a reasonable approach in patients with symptomatic hyponatremia and normal renal function.

In a 2024 systematic review of 96 cases of osmotic demyelination in adults published between 1997 and 2019, development of osmotic demyelination was predominant in women under 50 years of age with severe hyponatremia and rapid correction (19). Median admission serum sodium was 105 mEq/L, and more than 90% of patients had severe hyponatremia (< 120 mEq/L). Associated gastrointestinal tract disorders (39%), alcoholism (31%), and use of diuretics (27%) were common. Correction of hyponatremia was performed mainly with isotonic (47%) or hypertonic (34%) saline solution. In 10% of cases, osmotic demyelination occurred even with correction of less than 10 mEq/L/day, reinforcing the need for conservative targets for high-risk patients, (ie, 4-6 mEq/L/day). Other anecdotal reports have documented the occurrence of osmotic demyelination despite cautious correction of hyponatremia below 8 mmol/L per day (77).

Because patients with hyponatremia can rapidly correct even with normal saline, serum sodium should be measured every 4 hours to allow for fluid and electrolyte administration adjustments should serum sodium rise at a rate greater than 0.5 mEq/ml per hour. Sterns and colleagues suggested an even slower correction rate for chronic, severe hyponatremia, with a limit of 4 to 6 mEq/L/day increase in serum sodium (181). Separate professional organizations from the United States and Europe have published guidelines on the correction of hyponatremia. The limit, according to European guidelines, is 10 mmol/L per day (178; 179; 180). The United States guidelines are more specific, with a limit of 10 to 12 mmol/L per day with an additional recommended maximum correction of 8 mmol/L per day in cases where there is a high risk of osmotic demyelination syndrome, such as in patients with hypokalemia, alcoholism, malnutrition, or liver disease (74). The use of desmopressin to limit water diuresis has become common as a means of preventing the overcorrection of severe hyponatremia (174; 115).

V2-receptor antagonists, or vaptans, are safe and effective for treating hypervolemic and normovolemic hyponatremia. A study using either 7.5 or 15 mg daily doses of tolvaptan in the emergency department for the treatment of moderate to severe euvolemic or hypervolemic hypernatremia in 23 patients revealed that 15 mg/day dosing resulted in a dangerous overcorrection (> 12 mEq/L/24 h) in 42% of patients, whereas 7.5 mg/day dosing did not cause any dangerous overcorrections. Osmotic demyelination was not observed in either group after 1 month of follow-up (30).

For patients with end-stage kidney disease on hemodialysis, there is a risk of correcting hyponatremia too rapidly during dialysis. One proposed method for preventing this is to use a dialysate with a sodium concentration of 130 mEql/L and limit blood flow to 50 mL/min (199).

Limited evidence suggests that minocycline may help prevent osmotic demyelination syndrome from water diuresis (189). In rat models, using urea to correct mild chronic hyponatremia has less risk than vasopressin antagonists or hypertonic saline (57).

A prospective, multicenter, open-label, randomized clinical trial of 178 adult patients with symptomatic hyponatremia comparing continuous infusion versus rapid intermittent bolus therapy with hypertonic saline revealed that both approaches were effective and safe, with no difference in the risk of too-rapid correction (14). Rapid intermittent bolus therapy did have a lower incidence of needing therapeutic relowering and possibly better efficacy, suggesting that this should be the preferred treatment for symptomatic hyponatremia (14).

Hypernatremic osmotic demyelination. Prevention includes early recognition and gradual correction of hypernatremia (< 10 mEq/L/day) by oral and intravenous free water (84).

Differential diagnosis

Confusing conditions

In the appropriate clinical situation and with the classical clinical signs and symptoms, there is little difficulty in arriving at the diagnosis of osmotic demyelination syndrome. However, myelinolysis often occurs in the setting of critical illness, and symptoms may be masked in mechanically ventilated patients receiving paralytics or sedatives or in patients with an underlying metabolic or hypoxic encephalopathy.

Cases of central pontine myelinolysis have been confused with stroke (98; 141). For example, a 45-year-old alcoholic woman recently hospitalized for Wernicke encephalopathy presented with left hemiparesis and was initially suspected to have had a stroke (98). As part of a “code stroke” protocol, CT was performed, but the non-contrast brain CT and CT angiogram of the intracranial arteries were normal; however, a CT brain perfusion study demonstrated increased pontine blood flow. A subsequent MRI of the brain confirmed central pontine myelinolysis.

Alcoholic woman hospitalized for Wernicke encephalopathy, presented with left hemiparesis, and was suspected to have stroke (non-contrast CT)

CT image in a 45-year-old alcoholic woman with a recent hospitalization for Wernicke encephalopathy who presented with left hemiparesis and was initially suspected to have had a stroke. The axial, non-contrast CT was unrevealin...
Alcoholic woman hospitalized for Wernicke encephalopathy, presented with left hemiparesis, and was suspected to have stroke (CT perfusion)

CT perfusion images in a 45-year-old alcoholic woman with a recent hospitalization for Wernicke encephalopathy who presented with left hemiparesis and was initially suspected to have had a stroke. CT perfusion images at the lev...
Alcoholic woman hospitalized for Wernicke encephalopathy, presented with left hemiparesis, and was suspected to have stroke (MRI)

MRI in a 45-year-old alcoholic woman with a recent hospitalization for Wernicke encephalopathy who presented with left hemiparesis and was initially suspected to have had a stroke. (a) Axial T2-weighted image demonstrates high ...

From an imaging perspective, there can sometimes be overlap with acute disseminated encephalomyelitis, metronidazole poisoning, and motor neuron disease (84). In acute disseminated encephalomyelitis, MRI abnormalities predominate in cerebral and cerebellar cortices, subcortical and parieto-occipital white matter, centrum semiovale, cerebellar peduncles, and brainstem; the lesions are typically large, asymmetric, and irregular in morphology. Metronidazole poisoning manifests after metronidazole intake for more than 2 weeks; brain MRI demonstrates abnormal symmetric hyperintensities in the cerebellum, cerebral white matter, and corpus callosum. In motor neuron disease, a similar imaging appearance is observed, particularly that of hypernatremic osmotic demyelination (97; 96), but the clinical presentation is one of relentless progression.

Diagnostic workup

Osmotic demyelination syndrome can sometimes be detected with computed tomography (193; 82), but the sensitivity is low. MRI is the diagnostic modality of choice for demonstrating demyelination in the central pons, which is present in most patients with osmotic demyelination syndrome (46; 122; 167; 48). MRI is also the modality of choice for demonstrating extrapontine myelinolysis (48).

Ill-defined area of reduced density in central pons consistent with central pontine myelinolysis (CT)

This 40-year-old woman with chronic alcoholism presented with intractable headache for 3 days and progressively worsening unsteady gait requiring a wheelchair to ambulate. Electrolyte levels were normal. Central pontine myelino...
Areas of reduced density in subcortical white matter consistent with extrapontine myelinolysis (CT)

CT scan of the head showing scattered areas of reduced density in the subcortical white matter, including the frontal lobes and right parietal lobe, consistent with extrapontine myelinolysis. This 40-year-old woman with chronic...
Pontine myelinolysis (axial FLAIR MRI)

Axial FLAIR MRI demonstrating a centrally located area of increased signal in the pons typical for pontine myelinolysis. (Source: Dimitrov G, Naeva D, Duparinova R, Stratieva S, Manev V, Prinova K. Osmotic demyelination syndrom...
Peripheral high FLAIR signals within the central pons consistent with central pontine myelinolysis (MRI)

This 40-year-old woman with chronic alcoholism presented with intractable headache for 3 days and progressively worsening unsteady gait requiring a wheelchair to ambulate. Electrolyte levels were normal. Central pontine myelino...
Extrapontine myelinolysis (axial FLAIR MRI)

Axial FLAIR MRI demonstrating moderately homogeneous signal enhancement bilaterally symmetrical in the basal ganglia with symmetrical foci of enhancement in the posterior thalami typical for extrapontine myelinolysis. (Source: ...

Central pontine myelinolysis appears hyperintense on T2-weighted, FLAIR, and diffusion-weighted (DWI) images and hypointense on T1-weighted images. DWI can be helpful, particularly early in osmotic demyelination, with affected white matter showing hyperintensity on diffusion-weighted images associated with a decrease in apparent diffusion coefficient values (40; 159; 87; 54; 13; 55).

Central pons lesion in central pontine myelinolysis secondary to hyperglycemia (axial T2 MRI)

Axial T2‐weighted MRI showing a hyperintense lesion in the central pons in a patient with central pontine myelinolysis secondary to hyperglycemia. (Source: Sun WP, Wang YD, Gao S, Wang YF, Li DW. A rare presentation of central ...
Increased signal intensity in the lentiform and caudate nuclei in osmotic demyelination syndrome (axial FLAIR)

Axial FLAIR sequence at onset of symptoms in osmotic demyelination syndrome showing symmetrical increased signal intensity in the lentiform and caudate nuclei bilaterally. (Source: Siranart N, Nakaphan P, Viarasilpa V, Anukoolw...
Central pons region of hyperintensity in osmotic demyelination syndrome (axial FLAIR)

Axial FLAIR sequence 3 weeks after symptom onset in osmotic demyelination syndrome showing a homogenous region of hyperintensity in the central pons. (Source: Siranart N, Nakaphan P, Viarasilpa V, Anukoolwittaya P, Hemachudha P...
Central pons lesion in central pontine myelinolysis secondary to hyperglycemia (axial FLAIR)

Axial FLAIR sequence showing a hyperintense lesion in the central pons in a patient with central pontine myelinolysis secondary to hyperglycemia. (Source: Sun WP, Wang YD, Gao S, Wang YF, Li DW. A rare presentation of central p...
Central pons lesion in central pontine myelinolysis secondary to hyperglycemia (sagittal FLAIR MRI)

Sagittal FLAIR sequence showing a hyperintense lesion in the central pons in a patient with central pontine myelinolysis secondary to hyperglycemia. (Source: Sun WP, Wang YD, Gao S, Wang YF, Li DW. A rare presentation of centra...
Resolving hyperintensity in the pons in osmotic demyelination syndrome (axial FLAIR)

Axial FLAIR sequence 6 months after symptom onset in osmotic demyelination syndrome showing resolving hyperintensity in the pons. (Source: Siranart N, Nakaphan P, Viarasilpa V, Anukoolwittaya P, Hemachudha P. Hand knob sign in ...
Resolving hyperintensity in the basal ganglia in osmotic demyelination syndrome (axial FLAIR)

Axial FLAIR sequence 6 months after symptom onset in osmotic demyelination syndrome showing resolving hyperintensity in the basal ganglia bilaterally. (Source: Siranart N, Nakaphan P, Viarasilpa V, Anukoolwittaya P, Hemachudha ...
Central pons hyperintensity in osmotic demyelination syndrome (DWI)

Axial diffusion-weighted image (DWI) showing hyperintensity of the central pons in (orange arrow) in osmotic demyelination syndrome. (Source: Koul P, Harjpal P, Raghumahanti R. Osmotic demyelination syndrome: a rare clinical im...
Increased signal intensity in the lentiform and caudate nuclei in osmotic demyelination syndrome (DWI)

Diffusion-weighted imaging (DWI) at onset of symptoms in osmotic demyelination syndrome showing symmetrical increased signal intensity in the lentiform and caudate nuclei bilaterally. (Source: Siranart N, Nakaphan P, Viarasilpa...
Central pons lesion in central pontine myelinolysis secondary to hyperglycemia (axial T1 MRI)

Axial T1‐weighted MRI showing a mildly hypointense lesion in the central pons in a patient with central pontine myelinolysis secondary to hyperglycemia. (Source: Sun WP, Wang YD, Gao S, Wang YF, Li DW. A rare presentation of ce...

In central pontine myelinolysis, the central pons may show a trident-shaped area of hyperintensity (the trident sign, or omega sign) on axial T2-weighted or FLAIR images (121; 25; 20; 15; 95). The characteristic “trident” shape is attributed to selective involvement of the transverse pontine fibers and relatively sparing of the descending corticospinal tracts. Another sign of central pontine myelinolysis is the "piglet" (or "piglet face") sign in which the pons takes on a distinctive resemblance to the snout of a piglet on axial T2-weighted or FLAIR images, whereas the internal carotid arteries and the fourth ventricle form, respectively, the eyes and mouth (20; 15; 195; 95).

Trident-shaped appearance of central pons in osmotic demyelination syndrome (axial T2 MRI)

Trident-shaped appearance (trident sign or omega sign) of central pons in an axial T2-weighted image (blue arrow) in osmotic demyelination syndrome. The characteristic “trident”-shaped appearance is attributed to the involvemen...
"Piglet" sign of the upper pons (axial T2 MRI)

"Piglet" (or "piglet face") sign of the upper pons in an axial T2-weighted MRI sequence (green circle). In the ʺpiglet faceʺ sign, the pons takes on a distinctive resemblance to the snout of a piglet, whereas the internal carot...
"Piglet" (or "piglet face") sign of the upper pons (FLAIR MRI)

"Piglet" (or "piglet face") sign of the upper pons in FLAIR MRI sequence (red circle). In the ʺpiglet faceʺ sign, the pons takes on a distinctive resemblance to the snout of a piglet, whereas the internal carotid arteries and t...

Cortical laminar necrosis has been rarely observed in osmotic demyelination syndrome (37; 75; 154; 109; 172). The pathogenesis of cortical laminar necrosis in osmotic demyelination syndrome is multifactorial and involves blood-brain barrier breakdown, macrophage deposition, and demyelination (154; 172). Cortical laminar necrosis in osmotic demyelination syndrome may selectively involve the hand knob area of the precentral gyrus ("hand knob" sign); preferential involvement of the hand knob area may result from higher cortical metabolic activities in this area (172).

Precentral gyri hyperintensity, including the hand knob area (axial FLAIR)

Axial FLAIR sequence 3 weeks after symptom onset in osmotic demyelination syndrome showing hyperintensity in the precentral gyri bilaterally, including the hand knob area ("hand knob sign"). (Source: Siranart N, Nakaphan P, Via...
Resolving hyperintensity in the hand knob area in osmotic demyelination syndrome (axial FLAIR)

Axial FLAIR sequence 6 months after symptom onset in osmotic demyelination syndrome showing resolving hyperintensity in the hand knob area. (Source: Siranart N, Nakaphan P, Viarasilpa V, Anukoolwittaya P, Hemachudha P. Hand kno...

Fairly typical early MRI findings of osmotic demyelination syndrome are shown in a 34-year-old woman with longstanding diabetes a 44-year-old diabetic man in the following figures.

Longstanding uncontrolled diabetes mellitus, symmetric hyperintense lesions in the pons (MRI)

In a 34-year-old female with longstanding uncontrolled diabetes mellitus who presented with quadriparesis and dysphagia, laboratory investigations showed high HbA1c (12.3%), high blood glucose (278 mg/dL), increased serum osmol...
Longstanding uncontrolled diabetes mellitus, marked hyperintensity over the pons (FLAIR)

In a 34-year-old female with longstanding uncontrolled diabetes mellitus who presented with quadriparesis and dysphagia, laboratory investigations showed high HbA1c (12.3%), high blood glucose (278 mg/dL), increased serum osmol...
Longstanding uncontrolled diabetes mellitus, mildly hypointense lesion in central pons (MRI)

In a 34-year-old female with longstanding uncontrolled diabetes mellitus who presented with quadriparesis and dysphagia, laboratory investigations showed high HbA1c (12.3%), high blood glucose (278 mg/dL), increased serum osmol...
Bilateral hyperintensity in the pons and cerebellum in osmotic demyelination syndrome (MRI)

In this 44-year-old diabetic man with osmotic demyelination syndrome, axial T2-weighted MR images show bilateral hyperintensity in the pons and cerebellum. (Source: Shrestha S, Kharel S, Gautam S, et al. Pontine and bilateral c...

Hypernatremic osmotic demyelination has different imaging characteristics on MRI than osmotic demyelination resulting from the too-rapid correction of hyponatremia. MRI abnormalities associated with hypernatremic osmotic demyelination include bilateral T2-weighted or FLAIR hyperintensities involving the corpus callosum (especially the splenium), the internal capsule, cerebellar peduncles, pons, and hippocampus, with restricted diffusion along the corticospinal tracts and in the splenium of the corpus callosum (84). The bilateral symmetric hyperintensities in the corticospinal tracts lead to a picture of a “wine glass” pattern of hyperintensities on coronal images, a pattern that has previously been described in amyotrophic lateral sclerosis and leukodystrophies (97; 163; 96; 186; 38; 84).

Subcortical white matter lesions can be present in osmotic demyelination syndrome, and their demonstration should be attempted with enhanced MRI (28); the co-occurrence of pontine and other enhancing subcortical lesions is very suggestive of osmotic demyelination syndrome, especially after rapid correction of hyponatremia.

Rarely, microhemorrhages may be seen with osmotic demyelination syndrome, possibly from osmotic-injury-induced endothelial damage (134; 84).

The serial progression of neurologic lesions disclosed by MRI can be appreciated in the case of a 51-year-old man who developed osmotic demyelination syndrome due to rhabdomyolysis and hyperosmolar hyperglycemic syndrome following cardiogenic shock (88).

MRI on day 10 revealed only symmetrical hyperintensity in the putamen and posterior limb of the internal capsule on DWI and FLAIR images.

Osmotic demyelination syndrome due to rhabdomyolysis and hyperosmolar hyperglycemic syndrome following cardiogenic shock (DWI, day 10)

DWI MRI in 51-year-old man on day 10 after cardiogenic shock revealed symmetrical hyperintensity in the putamen and posterior limb of the internal capsule (arrow) on diffusion-weighted imaging (DWI). (Source: Katano K, Fuse N, ...
Osmotic demyelination syndrome due to rhabdomyolysis and hyperosmolar hyperglycemic syndrome following cardiogenic shock (FLAIR, day 10)

FLAIR MRI in 51-year-old man on day 10 after cardiogenic shock revealed only symmetrical hyperintensity in the putamen and posterior limb of the internal capsule (arrow) on FLAIR images. (Source: Katano K, Fuse N, Asano Y, et a...

MRI on day 16 revealed no changes in the findings except a loss of hyperintensity on DWI.

Osmotic demyelination syndrome due to rhabdomyolysis and hyperosmolar hyperglycemic syndrome following cardiogenic shock (DWI, day 16)

DWI MRI in a 51-year-old man on day 16 after cardiogenic shock revealed no changes in the findings except loss of hyperintensity on diffusion-weighted imaging (DWI). (Source: Katano K, Fuse N, Asano Y, et al. Osmotic demyelinat...

MRI on day 57 revealed symmetrical hyperintensity in the pons, cerebellar hemispheres, hippocampus, thalamus, and hypothalamus on FLAIR.

Osmotic demyelination syndrome due to rhabdomyolysis and hyperosmolar hyperglycemic syndrome following cardiogenic shock (FLAIR, day 57) (1)

FLAIR MRI in a 51-year-old man on day 57 after cardiogenic shock revealed symmetrical hyperintensity in the pons and cerebellar hemispheres (arrow). (Source: Katano K, Fuse N, Asano Y, et al. Osmotic demyelination syndrome due ...
Osmotic demyelination syndrome due to rhabdomyolysis and hyperosmolar hyperglycemic syndrome following cardiogenic shock (FLAIR, day 57) (2)

FLAIR MRI in a 51-year-old man on day 57 after cardiogenic shock revealed symmetrical hyperintensity in the hippocampus and hypothalamus (arrow). (Source: Katano K, Fuse N, Asano Y, et al. Osmotic demyelination syndrome due to ...
Osmotic demyelination syndrome due to rhabdomyolysis and hyperosmolar hyperglycemic syndrome following cardiogenic shock (FLAIR, day 57) (3)

FLAIR MRI in a 51-year-old man who developed osmotic demyelination syndrome due to rhabdomyolysis and hyperosmolar hyperglycemic syndrome following cardiogenic shock. MRI FLAIR images on day 57 revealed symmetrical hyperintensi...

In another case of osmotic demyelination syndrome, a 44-year-old man with severe hyponatremia (100 mmol/L) was treated with sodium supplementation with 3% hypertonic saline and water restriction; he developed altered mental status with agitation, limb rigidity, bradykinesia, and dystonia on hospital day 2. Brain MRI FLAIR and T2-weighted images initially showed no significant abnormalities, whereas diffusion-weighted imaging showed symmetrical high-intensity lesions at the head of the caudate nucleus and putamen (102).

Osmotic demyelination syndrome in a 44-year-old man with severe hyponatremia (1)

(100 mmol/L) This 44-year-old man was treated with sodium supplementation with 3% hypertonic saline and water restriction and developed altered mental status with agitation, limb rigidity, bradykinesia, and dystonia on hospital...
Osmotic demyelination syndrome in a 44-year-old man with severe hyponatremia (2)

(100 mmol/L) This 44-year-old man was treated with sodium supplementation with 3% hypertonic saline and water restriction and developed altered mental status with agitation, limb rigidity, bradykinesia, and dystonia on hospital...

DWI on hospital day 12 showed that the previous caudate nucleus and putamen lesions had become more conspicuous, and a new high-intensity lesion involving the central pons was evident, consistent with central pontine myelinolysis.

Osmotic demyelination syndrome in a 44-year-old man with severe hyponatremia (3)

(100 mmol/L). This 44-year-old man was treated with sodium supplementation with 3% hypertonic saline and water restriction and developed altered mental status with agitation, limb rigidity, bradykinesia, and dystonia on hospita...

There have been case reports of localized 18F-fluorodeoxyglucose uptake on PET and CT during active central pontine myelinolysis. The increased metabolism of attracted glial cells and macrophages as well as activated astrocytes during active disease are thought to be responsible for fluorodeoxyglucose uptake (156).

Special considerations

Pregnancy

To the extent that pregnant women are more likely to develop hyponatremia (eg, from hyperemesis gravidarum), pregnancy may carry an increased risk of osmotic demyelination syndrome (31). A woman with a twin pregnancy presented with central pontine myelinolysis and required emergency delivery to correct electrolyte and fluid balance, resulting in minimal sequelae for the mother (162); the twins were asymptomatic at 6 months of follow-up.

Liver disease

Hyponatremia is a common problem for patients with cirrhosis, and liver disease is a risk factor for osmotic demyelination syndrome. For patients with end-stage liver disease undergoing transplantation, risk factors for developing osmotic demyelination syndrome include severe pretransplant hyponatremia, the magnitude of change of serum sodium during transplantation, higher positive intraoperative fluid balance, and postoperative hemorrhagic complications. Correction of hyponatremia prior to transplantation along with multidisciplinary management to carefully manage fluid and electrolytes during and after surgery are important to minimize the risk of osmotic demyelination syndrome in this vulnerable population (41).

Children

Osmotic demyelination is less common in children than in adults.

A review of reported pediatric cases of osmotic demyelination syndrome in available English literature revealed that about half present with central pontine myelinolysis, a third with isolated extrapontine myelinolysis, and the remaining with combined central and extrapontine myelinolysis (17). There was no evident gender predisposition to osmotic demyelination in children. The highest prevalence was between ages 1 and 5 years. Sixty percent of affected children had a complete neurologic recovery. Although MRI is still preferred as the main diagnostic test, diffusion tensor imaging is more often used for prognostication. Other than supportive care, steroids and intravenous immunoglobulin are rarely used.

Media

References

01: Abbott R, Silber E, Felber J, Ekpo E. Osmotic demyelination syndrome. BMJ 2005;331(7520):829-30. PMID 16210283
02: Adams RD, Victor M, Mancall EL. Central pontine myelinolysis, a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry 1959;81:154-72.** PMID 13616772
03: Adrogue HJ, Tucker BM, Madias NE. Diagnosis and management of hyponatremia: a review. JAMA 2022;328(3):280-91.** PMID 35852524
04: Aegisdottir H, Cooray C, Wirdefeldt K, Piehl F, Sveinsson O. Incidence of osmotic demyelination syndrome in Sweden: A nationwide study. Acta Neurol Scand 2019;140(5):342-9. PMID 31343728
05: Ahmed A, Tschetter PA, Krasowski MD, Engelman A. Massive ethylene glycol poisoning triggers osmotic demyelination syndrome. J Emerg Med 2014;46(3):e69-74. PMID 24199725
06: Ahmed M, Moffett P. Osmotic demyelination syndrome in a patient with tremors. Cureus 2022;14(10):e30076. PMID 36381866
07: An JY, Park SK, Han SR, Song IU. Central pontine and extrapontine myelinolysis that developed during alcohol withdrawal, without hyponatremia, in a chronic alcoholic. Intern Med 2010;49(6):615-8. PMID 20228603
08: Anand K, Ranjan Rout R, Subbaiah M, Dorairajan G, Sagili H. Rare complication of hyperemesis gravidarum-central pontine myelinolysis: a case report. J Gynecol 2017;2(2):138.
09: Andereggen L, Remonda L. Pontine neoplasm or myelinolysis despite normal sodium levels. World Neurosurg 2020;140:63-4. PMID 32416240
10: Antonioni A, Rispoli V, Fazio P, Golfrè Andreasi N, Govoni V, Granieri E. Development of Parkinsonism in a patient with central pontine myelinolysis. Neurol Int 2022;14(3):673-7. PMID 36135990
11: Aoki R, Morimoto T, Takahashi Y, Saito H, Fuchigami T, Takahashi S. Extrapontine myelinolysis associated with severe hypernatremia in infancy. Pediatr Int 2016;58(9):936-9. PMID 27463219
12: Ashrafian H, Davey P. A review of the causes of central pontine myelinosis: yet another apoptotic illness? Eur J Neurol 2001;8(2):103-9. PMID 11430268
13: Babanrao SA, Prahladan A, Kalidos K, Ramachandran K. Osmotic myelinolysis: does extrapontine myelinolysis precede central pontine myelinolysis? Report of two cases and review of literature. Indian J Radiol Imaging 2015;25(2):177-83. PMID 25969642
14: Baek SH, Jo YH, Ahn S, Medina-Liabres K, Oh YK, Lee JB, Kim S. Risk of overcorrection in rapid intermittent bolus vs slow continuous infusion therapies of hypertonic saline for patients with symptomatic hyponatremia: The SALSA randomized clinical trial. JAMA Intern Med 2021;181(1):81-92.** PMID 33104189
15: Balcerac A, Nichelli L, Demeret S, Le Guennec L. The piglet and the trident sign in osmotic demyelination syndrome. Intensive Care Med 2021;47(4):476-7. PMID 33517472
16: Bansal LR. Therapeutic effect of steroids in osmotic demyelination of infancy. Child Neurol Open 2018;5:2329048X18770576. PMID 29687030
17: Bansal LR, Zinkus T. Osmotic demyelination syndrome in children. Pediatr Neurol 2019;97:12-7. PMID 31128892
18: Baouahi H, Doumiri M. Encéphalopathie de Wernicke compliquant l'hyperémèse gravidique et associée à une myélinolyse centropontique [Wernicke encephalopathy complicating hyperemesis gravidarum and associated with pontine myelinolysis]. Pan Afr Med J 2014;19:340. PMID 25922629
19: Bastos AP, Rocha PN. Osmotic demyelination as a complication of hyponatremia correction: a systematic review. J Bras Nefrol 2024;46(1):47-55. PMID 37523718
20: Beh SC. Temporal evolution of the trident and piglet signs of osmotic demyelination syndrome. J Neurol Sci 2017;373:268-73. PMID 28131203
21: Berl T, Rastegar A. A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion. Am J Kidney Dis 2010;55(4):742-8. PMID 20338465
22: Berry K, Olszewski J. Central pontine myelinolysis, a case report. Neurology 1963;13:531-7.**
23: Berry K, Rubin JB, Lai JC. Osmotic demyelination syndrome in hospitalized patients with cirrhosis: analysis of the National Inpatient Sample (NIS). J Clin Gastroenterol 2022;56(3):280-3. PMID 33731600
24: Bhatia S, Kapoor AK, Sharma A, Gupta R, Kataria S. Cerebral encephalopathy with extrapontine myelinolysis in a case of postpartum hypernatremia. Indian J Radiol Imaging 2014;24(1):57-60. PMID 24851006
25: Biotti D, Durupt D. A trident in the brain, central pontine myelinolysis. Pract Neurol 2009;9(4):231-2. PMID 19608774
26: Bornke C, Ellrichmann G, Schneider R, Lukas C. Osmotic demyelination syndrome. BMJ Case Rep 2014;2014:bcr2014204742. PMID 25006057
27: Bose P, Kunnacherry A, Maliakal P. Central pontine myelinolysis without hyponatraemia. J R Coll Physicians Edinb 2011;41(3):211-4. PMID 21949915
28: Bourgouin PM, Chalk C, Richardson J, Duang H, Vezina JL. Subcortical white matter lesions in osmotic demyelination syndrome. AJNR Am J Neuroradiol 1995;16(7):1495-7. PMID 7484639
29: Brunner JE, Redmond JM, Haggar AM, Kruger DF, Elias SB. Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: a prospective magnetic resonance imaging study. Ann Neurol 1990;27(1):61-6. PMID 2301929
30: Castello LM, Baldrighi M, Panizza A, Bartoli E, Avanzi GC. Efficacy and safety of two different tolvaptan doses in the treatment of hyponatremia in the emergency department. Intern Emerg Med 2017;12(7):993-1001. PMID 27444946
31: Castillo RA, Ray RA, Yaghmai F. Central pontine myelinolysis and pregnancy. Obstet Gynecol 1989;73(3 Pt 2):459-61. PMID 2915874
32: Chang KY, Lee IH, Kim GJ, Cho K, Park HS, Kim HW. Plasma exchange successfully treats central pontine myelinolysis after acute hypernatremia from intravenous sodium bicarbonate therapy. BMC Nephrol 2014;15:56. PMID 24708786
33: Chason JL, Landers JW, Gonzalez JE. Central pontine myelinolysis. J Neurol Neurosurg Psychiatry 1964;27:317-25. PMID 14200786
34: Chatterjee K, Fernandes AB, Goyal S, Shanker S. Central pontine myelinolysis in a case of alcohol dependence syndrome. Ind Psychiatry J 2015;24(2):198-201. PMID 27212829
35: Chaudhary A, Chaudhary A, Yadav RS, Shrestha Y, Shah R. Pediatric osmotic demyelination syndrome in a case of type 1 diabetes mellitus with diabetic ketoacidosis. Clin Case Rep 2022;10(3):e05584. PMID 35340640
36: Chhabra A, Kaushik R, Kaushik RM, Goel D. Extra-pontine myelinolysis secondary to hypernatremia induced by postpartum water restriction. Neuroradiol J 2017;30(1):84-7. PMID 28059675
37: Cho AH, Choi CG, Lee SA. Cortical laminar necrosis associated with osmotic demyelination syndrome. J Clin Neurol 2005;1(2):174-6. PMID 20396465
38: Choudhary G, Qureshi F, Arora A, Kothari N, Tiwari S, Bhatia P. Postpartum hypernatremia with extrapontine rhabdomyelinolysis: a case report. Qatar Med J 2022;2022(4):45. PMID 36304065
39: Corona G, Simonetti L, Giuliani C, Sforza A, Peri A. A case of osmotic demyelination syndrome occurred after the correction of severe hyponatraemia in hyperemesis gravidarum. BMC Endocr Disord 2014;14:34. PMID 24725751
40: Cramer SC, Stegbauer KC, Schneider A, Mukai J, Maravilla KR. Decreased diffusion in central pontine myelinolysis. AJNR Am J Neuroradiol 2001;22(8):1476-9. PMID 11559493
41: Crismale JF, Meliambro KA, DeMaria S Jr, Bronster DB, Florman S, Schiano TD. Prevention of the osmotic demyelination syndrome after liver transplantation: a multidisciplinary perspective. Am J Transplant 2017;17(10):2537-45. PMID 28422408
42: Dahal A, Bhattarai AM, Bhattarai AM, Pathak BD, Karki A, Aryal E. Central pontine myelinolysis in a chronic alcoholic patient with mild hyponatremia: a case report. Ann Med Surg (Lond) 2022;78:103736. PMID 35585991
43: Davenport C, Liew A, Vic Lau P, et al. Central pontine myelinolysis secondary to hypokalaemic nephrogenic diabetes insipidus. Ann Clin Biochem 2010;47(Pt 1):86-9. PMID 19940203
44: de Morais BS, Carneiro FS, Araújo Rde M, Araújo GF, de Oliveira RB. Central pontine myelinolysis after liver transplantation: is sodium the only villain? Case report. Rev Bras Anestesiol 2009;59(3):344-9. PMID 19488548
45: de Souza A. Movement disorders and the osmotic demyelination syndrome. Parkinsonism Relat Disord 2013;19(8):709-16.** PMID 23660544
46: DeWitt LD, Buonanno FS, Kistler JP, et al. Central pontine myelinolysis: demonstration by nuclear magnetic resonance. Neurology 1984;34(5):570-6. PMID 6538649
47: Dhadwad J, Chitnis A. Extra-pontine myelinolysis after rapid correction of hyponatremia responding to levodopa. Cureus 2024;16(1):e52707. PMID 38384610
48: Dimitrov G, Naeva D, Duparinova R, Stratieva S, Manev V, Prinova K. Osmotic demyelination syndrome amidst COVID-19: a case report with literature review. Neurologia (Engl Ed) 2024;39(2):213-7. PMID 38460994
49: Donnelly H, Connor S, Quirk J. Central pontine myelinolysis secondary to hyperglycaemia. Pract Neurol 2016;16(6):493-5. PMID 27407176
50: Dornonville de la Cour K. Udvikling af central pontinmyelinolyse hos en patient med kun let hyponatriæmi [Development of central pontin myelinolysis in a patient with light hyponatraemia]. Ugeskr Laeger 2013;175(39):2254-5. PMID 24063712
51: Feng XM, Zhao T, Zhou CK, Liu JY. Psychiatric symptoms and limb tremors associated with central pontine myelinolysis: a case of alcoholism without hyponatremia. Exp Ther Med 2016;12(5):3485-7. PMID 27882183
52: Ferreira GS, Watanabe AL, Trevizoli NC, et al. Refractory hypernatremia and osmotic demyelination syndrome after liver transplantation: a case report. Transplant Proc 2022;54(5):1376-9. PMID 35760624
53: Fitts W, Vogel AC, Mateen FJ. The changing face of osmotic demyelination syndrome: a retrospective, observational cohort study. Neurol Clin Pract 2021;11(4):304-10.** PMID 34484930
54: Forster A, Nölte I, Wenz H, et al. Value of diffusion-weighted imaging in central pontine and extrapontine myelinolysis. Neuroradiology 2013;55(1):49-56. PMID 22932916
55: Furtado C, Nayak S, Jadun C, Srivastava S, Hashim Z. Radiological appearance and imaging techniques in the diagnosis of advanced central pontine myelinolysis. Cureus 2022;14(10):e30328. PMID 36407248
56: Gankam-Kengne F, Couturier BS, Soupart A, Brion JP, Decaux G. Osmotic stress-induced defective glial proteostasis contributes to brain demyelination after hyponatremia treatment. J Am Soc Nephrol 2017;28(6):1802-13. PMID 28122966
57: Gankam-Kengne F, Couturier BS, Soupart A, Decaux G. Urea minimizes brain complications following rapid correction of chronic hyponatremia compared with vasopressin antagonist or hypertonic saline. Kidney Int 2015;87(2):323-31. PMID 25100046
58: Gankam-Kengne F, Nicaise C, et al. Astrocytes are an early target in osmotic demyelination syndrome. J Am Soc Nephrol 2011;22(10):1834-45. PMID 21885671
59: Garcia-Grimshaw M, Jiménez-Ruiz A, Ruiz-Sandoval JL, Cantú-Brito C, Chiquete E. Osmotic demyelination syndrome in patients with non-Hodgkin lymphoma: a case report and literature review. Int J Neurosci 2023;133(3):233-7. PMID 33765889
60: Gayathri DK, Dhayalen K, Chia YK, Fung YK. Plasmapheresis to treat osmotic demyelination syndrome from overly rapid plasma sodium correction. Med J Malaysia 2019;74(4):331-2. PMID 31424043
61: Georgy V, Mullhi D, Jones AF. Central pontine myelinolysis following “optimal” rate of correction of hyponatraemia with a good clinical outcome. Ann Clin Biochem 2007;44(Pt 5):488-90. PMID 17761038
62: Ghomari CF, Misgault B, Diallo AO, Durand H, Bund C, Namer IJ. Sequential brain perfusion findings in a case of osmotic demyelination syndrome. Clin Nucl Med 2023;48(1):52-53. PMID 36240840
63: Giannetti AV, Pittella JE. Ischemic and hemorrhagic necrosis of the pons with anatomical location similar to that of central pontine myelinolysis in a chronic alcoholic patient. Clin Neuropathol 1993;12(3):156-9. PMID 8324964
64: Gocht A, Colmant HJ. Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropathol 1987;6(6):262-70.** PMID 3322623
65: Goldman JE, Horoupian DS. Demyelination of the lateral geniculate nucleus in central pontine myelinolysis. Ann Neurol 1981;9(2):185-9. PMID 7235634
66: Guerrero WR, Dababneh H, Nadeau SE. Hemiparesis, encephalopathy, and extrapontine osmotic myelinolysis in the setting of hyperosmolar hyperglycemia. J Clin Neurosci 2013;20(6):894-6. PMID 23477877
67: Han MJ, Kim DH, Kim YH, Yang IM, Park JH, Hong MK. a case of osmotic demyelination presenting with severe hypernatremia. Electrolyte Blood Press 2015;13(1):30-6. PMID 26240598
68: Harris CP, Townsend JJ, Baringer JR. Symptomatic hyponatraemia: can myelinolysis be prevented by treatment? J Neurol Neurosurg Psychiatry 1993;56(6):626-32. PMID 8509775
69: Hart BL, Eaton RP. Images in clinical medicine. Osmotic myelinolysis. N Engl J Med 1995;333(19):1259. PMID 7566003
70: Hawthorne KM, Compton CJ, Vaphiades MS, Roberson GH, Kline LB. Ocular motor and imaging abnormalities of midbrain dysfunction in osmotic demyelination syndrome. J Neuroophthalmol 2009;29(4):296-9. PMID 19952903
71: Hegazi MO, Mashankar A. Central pontine myelinolysis in the hyperosmolar hyperglycaemic state. Med Princ Pract 2013;22(1):96-9. PMID 22922267
72: Herath HM, Pahalagamage SP, Senanayake S. Tongue fasciculations with denervation pattern in osmotic demyelination syndrome: a case report of diagnostic dilemma. BMC Res Notes 2018;11(1):177. PMID 29540223
73: Higinbotham A, Nayate AP. Unusual progression of osmotic demyelination after liver transplantation on MRI brain. Radiol Case Rep 2021;17(3):604-9. PMID 34987689
74: Hoorn EJ, Zietse R. Diagnosis and treatment of hyponatremia: compilation of the guidelines. J Am Soc Nephrol 2017;28(5):1340-9. PMID 28174217
75: Howard SA, Barletta JA, Klufas RA, Saad A, De Girolami U. Best cases from the AFIP: osmotic demyelination syndrome. Radiographics 2009;29(3):933-8. PMID 19448125
76: Huq S, Wong M, Chan H, Crimmins D. Osmotic demyelination syndromes: central and extrapontine myelinolysis. J Clin Neurosci 2007;14(7):684-8. PMID 17462902
77: Hwang C. Osmotic demyelination syndrome in a high-risk patient despite cautious correction of hyponatremia. Electrolyte Blood Press 2023;21(2):61-5. PMID 38152601
78: Jacob S, Gupta H, Nikolic D, Gundogdu B, Ong S. Central pontine and extrapontine myelinolysis: the great masquerader-an autopsy case report. Case Rep Neurol Med 2014;2014:745347. PMID 24716023
79: Jahan M, Sharma S, Rehmani R. Osmotic demyelination syndrome despite appropriate hyponatremia correction. Cureus 2020;12(5):e8209. PMID 32577327
80: Jain E, Kotwal S, Gnanaraj J, Khaliq W. Osmotic demyelination after rapid correction of hyperosmolar hyperglycemia. Cureus 2023;15(2):e34551. PMID 36874309
81: Jain N, Phadke RV, Chauhan G, Ambesh SP. Osmotic demyelination syndrome in the setting of hypernatremia. Neurol India 2018;66(2):559-60. PMID 29547197
82: Jamil M, Salam A, Joseph Benher BM, Rehman S, Jamil J, Suleyman G. A case of alcohol withdrawal-induced central and extrapontine myelinolysis. Cureus 2023;15(7):e41640. PMID 37565130
83: Jin X, Wang Y. Case report: osmotic demyelination syndrome after transcatheter aortic valve replacement: case report and review of current literature. Front Med (Lausanne) 2022;9:915981. PMID 35795632
84: Kale PG, Meghana D, Devi BV. Case of the week [Postpartum hypernatremic osmotic demyelination]. Am J Neuroradiol. Accessed March 24, 2023. Available at: https://www.ajnr.org/content/cow/07142022. July 14, 2022.
85: Kallakatta RN, Radhakrishnan A, Fayaz RK, Unnikrishnan JP, Kesavadas C, Sarma SP. Clinical and functional outcome and factors predicting prognosis in osmotic demyelination syndrome (central pontine and/or extrapontine myelinolysis) in 25 patients. J Neurol Neurosurg Psychiatry 2011;82(3):326-31.** PMID 20826870
86: Kamath M, Manjunath S. Idiopathic central pontine and extrapontine myelinolysis in a child. J Pediatr Neurosci 2019;14(2):97-9.** PMID 31516629
87: Kang SY, Ma HI, Lim YM, et al. Normal diffusion-weighted MRI during the acute stage of central pontine myelinolysis. Int J Neurosci 2012;122(8):477-9. PMID 22463602
88: Katano K, Fuse N, Asano Y, et al. Osmotic demyelination syndrome due to rhabdomyolysis and hyperosmolar hyperglycemic syndrome following cardiogenic shock. Case Rep Crit Care 2021;2021:8083731. PMID 34868688
89: Khan S, Das S, Batool W, Khan BS, Khan M. Rapid correction of hyponatremia with isotonic saline leading to central pontine myelinolysis. Cureus 2023;15(4):e38342. PMID 37266057
90: Kim JH, Kim SH, Jeong HJ, Sim YJ, Kim DK, Kim GC. Central pontine myelinolysis induced by alcohol withdrawal: a case report. Ann Rehabil Med 2017;41(1):148-52. PMID 28289647
91: Kleinschmidt-DeMasters BK, Norenberg MD. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science 1981;211(4486):1068-70.** PMID 7466381
92: Kleinschmidt-Demasters BK, Rojiani AM, Filley CM. Central and extrapontine myelinolysis: then…and now. J Neuropathol Exp Neurol 2006;65(1):1-11.** PMID 16410743
93: Kobayashi S, Mizuno N, Yokoi K, Mori T, Sohara E, Uchida S. Congenital nephrogenic diabetes insipidus presenting as osmotic demyelination syndrome in infancy: a case report. Medicine (Baltimore) 2022;101(3):e28552. PMID 35060513
94: Koleva M, Beminova V, Topalov N, Slavkova E, Asenova A. Myelinolysis and rhabdomyolysis in a child with severe hypernatremia. Bulgarian Neurol 2021;22(2):79-83.
95: Koul P, Harjpal P, Raghumahanti R. Osmotic demyelination syndrome: a rare clinical image. Diagnostics (Basel) 2023;13(21):3393. PMID 37958289
96: Kumar S, Aga P, Gupta A, Kohli N. Juvenile amyotrophic lateral sclerosis: classical wine glass sign on magnetic resonance imaging. J Pediatr Neurosci 2016;11(1):56-7. PMID 27195035
97: Kuruvilla A, Joseph S. “Wine glass” appearance: a unique MRI observation in a case of primary lateral sclerosis. Neurol India 2002;50(3):306-9. PMID 12391458
98: Kusel K, Azzam O, Youssef A, Prentice D. Alcoholic pontine myelinolysis: beware the stroke mimic. BJR Case Rep 2021;7(4):20210005. PMID 35047202
99: Kusumoto K, Koriyama N, Kojima N, Ikeda M, Nishio Y. Central pontine myelinolysis during treatment of hyperglycemic hyperosmolar syndrome: a case report. Clin Diabetes Endocrinol. 2020;6(1):23. PMID 33292743
100: Laureno R. Central pontine myelinolysis following rapid correction of hyponatremia. Ann Neurol 1983;13(3):232-42. PMID 6847135
101: Laureno R, Karp BI. Myelinolysis after correction of hyponatremia. Ann Intern Med 1997;126(1):57-62. PMID 8992924
102: Lee C, Ko C. Temporal brain mri changes from extrapontine myelinolysis to central pontine myelinolysis: a case report. Cureus 2021;13(11):e19318. PMID 34909286
103: Lee JH, Kim CS, Bae EH, Kim SW, Ma SK. Osmotic demyelination syndrome associated with hypernatremia caused by lactulose enema in a patient with chronic alcoholism. Electrolyte Blood Press 2021;19(1):15-18. PMID 34290820
104: Lee KB, Hong BY, Kim JS, Son DB, Choi SI, Lim SH. The effect of white matter integrity on functional outcome in central pontine demyelination. J Phys Ther Sci 2019;31(8):698-701. PMID 31528012
105: Leens C, Mukendi R, Foret F, Hacourt A, Devuyst O, Colin IM. Central and extrapontine myelinolysis in a patient in spite of a careful correction of hyponatremia. Clin Nephrol 2001;55(3):248-53. PMID 11316247
106: Leslie KO, Robertson AS, Norenberg MD. Central pontine myelinolysis: an osmotic gradient pathogenesis. J Neurol Neurosurg Psychiatry 1980;39:370.
107: Lien YH, Shapiro JI, Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest 1991;88(1):303-9. PMID 2056123
108: Lim GH, Lee SA, Kim HM, Kim JH, Kim HW. A case of central pontine myelinolysis associated with hypokalemia in hyperemesis gravidarum. J Korean Neurol Assoc 2007;25(2):260-2.
109: Liu X, Zhao X, Yang J, Han X, Ruan X, Du Y. Cortical laminar necrosis following the rapid correction of drug-induced hyponatremia. Neurol Sci 2015;36(9):1725-7. PMID 25981229
110: Lodhi MU, Saleem TS, Kuzel AR, et al. "Beer potomania" - A syndrome of severe hyponatremia with unique pathophysiology: case studies and literature review. Cureus 2017;9(12):e2000. PMID 29507848
111: Logan C, Asadi H, Kok HK, et al. Neuroimaging of chronic alcohol misuse. J Med Imaging Radiat Oncol 2017;61(4):435-40. PMID 27987266
112: Lohr JW. Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia. Am J Med 1994;96(5):408-13.** PMID 8192171
113: Lopez-Sendon Moreno J, Vera Lechuga R, Estévez Santé S, Navacerrada Barrero FJ, Corral Corral I. Mielinolisis central pontina y extrapontina: cuadro clínico, resonancia magnética cerebral y evolución en 13 pacientes [Central pontine and extrapontine myelinolysis: clinical case, brain magnetic resonance and evolution in 13 patients]. Neurologia 2009;24(3):165-9. PMID 19418292
114: Lv X, Hong Q, Lin X, Chen W, Tian Y. Osmotic demyelination syndrome: clinical, neuroimaging characteristics, and outcomes in a series of 18 cases. Biomed Res Int 2021;2021:9944632. PMID 34136577
115: MacMillan TE, Cavalcanti RB. Outcomes in severe hyponatremia treated with and without desmopressin. Am J Med 2018;131(3):317.e1-317.e10. PMID 29061503
116: Malhotra K, Ortega L. Central pontine myelinolysis with meticulous correction of hyponatraemia in chronic alcoholics. BMJ Case Rep 2013;2013:bcr2013009970. PMID 23813514
117: Martin RJ. Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry 2004;75(Suppl 3):iii22-8.** PMID 15316041
118: Marques P, Gunawardana K, Grossman A. Transient diabetes insipidus in pregnancy. Endocrinol Diabetes Metab Case Rep 2015;2015:150078. PMID 26524979
119: Mascarenhas JV, Jude EB. Central pontine myelinolysis: electrolytes and beyond. BMJ Case Rep 2014;2014:bcr2013203516. PMID 24682140
120: McKee AC, Winkelman MD, Banker BQ. Central pontine myelinolysis in severely burned patients: relationship to serum hyperosmolality. Neurology 1988;38(8):1211-7. PMID 3399069
121: Miller GM, Baker HL Jr, Okazaki H, Whisnant JP. Central pontine myelinolysis and its imitators: MR findings. Radiology 1988;168(3):795-802. PMID 3406409
122: Mir WA, Shrestha DB, Aryal BB, Reddy VK, Yadullahi MA. Central pontine myelinolysis secondary to hyperglycemia in a young patient. Cureus 2021;13(10):e18495. PMID 34754656
123: Muaddi L, Osman O, Clark B. Topiramate-induced severe electrolyte abnormalities and hypernatremia leading to central pontine myelinolysis. BMJ Case Rep 2021;14(11):e245870. PMID 34848414
124: Murao S, Kiuchi T, Hasegawa M, Yoshikawa R. Pontine lesion in hyperglycemic crises: relevance to osmotic demyelination syndrome and posterior reversible encephalopathy syndrome. J Diabetes Investig 2023;14(3):486-8. PMID 36458523
125: Murase T, Sugimura Y, Takefuji S, Oiso Y, Murata Y. Mechanisms and therapy of osmotic demyelination. Am J Med 2006;119(7 Suppl 1):S69-73. PMID 16843088
126: Murphy CJ, Cathcart PL, Olson AP. Those eyes don't lie: a case of osmotic demyelination syndrome in a patient with hepatic encephalopathy. Diagnosis (Berl) 2016;3(2):81-5. PMID 29536888
127: Murthy SB, Izadyar S, Dhamne M, Kass JS, Goldsmith CE. Osmotic demyelination syndrome: variable clinical and radiologic response to intravenous immunoglobulin therapy. Neurol Sci 2013;34(4):581-4. PMID 22491911
128: Musana AK, Yale SH. Central pontine myelinolysis: case series and review. WMJ 2005;104(6):56-60. PMID 16218318
129: Mustafa OG, Haq M, Dashora U, Castro E, Dhatariya KK; Joint British Diabetes Societies (JBDS) for Inpatient Care Group. Management of hyperosmolar hyperglycaemic state (HHS) in adults: an updated guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care Group. Diabet Med 2023;40(3):e15005. PMID 36370077
130: Mustajoki S. Severe hyponatraemia (P-Na < 116 mmol/l) in the emergency department: a series of 394 cases. Intern Emerg Med 2023;18(3):781-9. PMID 36800070
131: Naik KR, Saroja AO. Seasonal postpartum hypernatremic encephalopathy with osmotic extrapontine myelinolysis and rhabdomyolysis. J Neurol Sci 2010;291(1-2):5-11.** PMID 20129624
132: Nelson NR, Tompkins MG, Thompson Bastin ML. Plasma exchange as treatment for osmotic demyelination syndrome: case report and review of current literature. Transfus Apher Sci 2019;58(6):102663. PMID 31759898
133: Nguyen PC, Dunstan M, Kumar B, Low MS. Rare case of diffuse large B-cell lymphoma presenting with central pontine myelinolysis. BMJ Case Rep 2021;14(9):e242924. PMID 34518176
134: Norenberg MD. A hypothesis of osmotic endothelial injury. A pathogenetic mechanism in central pontine myelinolysis. Arch Neurol 1983;40(2):66-9.** PMID 6824451
135: Norenberg MD. Central pontine myelinolysis: historical and mechanistic considerations. Metab Brain Dis 2010;25(1):97-106.** PMID 20182780
136: Norenberg MD, Leslie KO, Robertson AS. Association between rise in serum sodium and central pontine myelinolysis. Ann Neurol 1982;11(2):128-35.** PMID 7073246
137: Norenberg MD, Papendick RE. Chronicity of hyponatremia as a factor in experimental myelinolysis. Ann Neurol 1984;15(6):544-7.** PMID 6742788
138: Ocak O, Çelik H, Korkmazer B, Ocak B, Karaman HI. Central pontine myelinolysis due to chronic alcohol use: case report. Acta Neurol Taiwan 2020;29(4):119-23. PMID 34018171
139: Ochiai H, Uenishi E. Early relowering of serum sodium concentration overcomes disturbances in consciousness during hyponatremia overcorrection and prevents osmotic demyelination syndrome. Intern Med 2018;57(16):2353-7. PMID 30111674
140: Oke IO, Mughees W, Patel H, Oladunjoye O, York E. A case of osmotic demyelination syndrome in a chronic alcoholic with moderate hyponatremia. Cureus 2021;13(5):e15129. PMID 34159031
141: Olowoporoku IG, Digala LP, Attele DP. Central Pontine Myelinolysis: A Case Report of Persistent Hyperglycemia With Normal Serum Sodium. Cureus 2022;14(9):e29470. PMID 36312619
142: Paguirigan A, Lefken EB. Central pontine myelinolysis. Neurology 1969;19(10):1007-11.** PMID 5387593
143: Park K, Kim SB, Yoon SS, Woo HG. Osmotic demyelination syndrome caused by rapid correction of hyperammonemia and continuous hyperbilirubinemia: a case report and review of the literature. Encephalitis 2023;3(4):119-24. PMID 37797653
144: Patel PD, Botre A, Patange A, Jadhav N, Shah H. A case of osmotic encephalopathy in osmotic demyelination syndrome with severe hypernatremia. J Evol Med Dent Sci 2019;8(11):819.
145: Paz P, Pan J, Ball S. Teaching neuroimages: extrapontine osmotic demyelination in hypernatremia. Neurology 2020;94(16):e1780-1. PMID 32221025
146: Phajir Vishwanath SR, Sekhar M, Bele K, Chandrashekar RK. Postpartum hypernatremic cerebral encephalopathy with osmotic myelinolysis: Report of two cases and review with emphasis on magnetic resonance imaging findings. Int J Adv Med Health Res 2015;2:112-5.
147: Pham CT, Kassab HS, Johnston JP. Evaluation of serum sodium correction rates for management of hyponatremia in hospitalized patients. Ann Pharmacother 2022;56(2):131-8. PMID 34027713
148: Proskynitopoulos PJ, Szycik G, Bleich S, Janke E, Glahn A. Das Auftreten der zentralen pontinen Myelinolyse während des qualifizierten Entzugs von Alkohol. Ein Fallbericht [Central pontine myelinolysis during qualified alcohol withdrawal therapy. A case report]. Neuropsychiatr 2020;34(4):175-8. PMID 33230716
149: Qu HL, Sun XY, Dai YJ. Central pontine myelinolysis: a rare finding in hyperosmolar hyperglycemia. Front Neurol 2023;14:1216328. PMID 37941579
150: Quigley N, Garneau AP, Haydock L, Isenring P. Extreme hyponatremia complicated by osmotic demyelination in a previously healthy young individual. Can J Kidney Health Dis 2022;9:20543581221130686. PMID 36406868
151: Riggs JE. Neurologic manifestations of electrolyte disturbances. Neurol Clin 2002;20(1):227-39, vii.** PMID 11754308
152: Riggs JE, Hogg JP. Central pontine myelinolysis: association with parenteral magnesium administration. Mil Med 2000;165(6):494-5. PMID 10870372
153: Riggs JE, Schochet SS Jr. Osmotic stress, osmotic myelinolysis, and oligodendrocyte topography. Arch Pathol Lab Med 1989;113(12):1386-8.** PMID 2589951
154: Roh JH, Kim JH, Oh K, Kim SG, Park KW, Kim BJ. Cortical laminar necrosis caused by rapidly corrected hyponatremia. J Neuroimaging 2009;19(2):185-7. PMID 18494778
155: Romero Calvo L, Garcia-Blanco MJ, Valenzuela F, Álvarez Granda J. Osmotic demyelination syndrome in a normonatremic patient under treatment with proton pump inhibitors. Cureus 2023;15(8):e44472. PMID 37791144
156: Ronne F, Tfelt-Hansen PC, Rørdam L. Central pontine myelinolysis and localized fluorodeoxyglucose uptake seen on 18F-FDG PET/CT. World J Nucl Med 2017;16(1):56-8. PMID 28217021
157: Rosenberg C, Rhodes M. Hyperammonemia in the setting of Roux-en-Y gastric bypass presenting with osmotic demyelination syndrome. J Community Hosp Intern Med Perspect 2021;11(5):708-12. PMID 34567470
158: Ruiz S, Alzieu M, Niquet L, Vergne S, Lathuile D, Campistron J. Hyponatrémie sévère et myélinolyse centropontine : attention aux cofacteurs! [Severe hyponatraemia and central pontine myelinolysis: be careful with other factors!]. Ann Fr Anesth Reanim 2009;28(1):96-9. PMID 19097847
159: Ruzek KA, Campeau NG, Miller GM. Early diagnosis of central pontine myelinolysis with diffusion-weighted imaging. AJNR Am J Neuroradiol 2004;25(2):210-3. PMID 14970019
160: Sajith J, Ditchfield A, Katifi HA. Extrapontine myelinolysis presenting as acute parkinsonism. BMC Neurol 2006;6:33. PMID 16961933
161: Sakai T, Tomimoto H. [Central pontine myelinolysis developed during alcohol withdrawal in a chronic alcoholic with hyperosmolar hyperglycemic state]. Rinsho Shinkeigaku 2014;54(2):116-23. PMID 24583585
162: Sanchez-Ferrer ML, Prieto-Sánchez MT, Orozco-Fernández R, Machado-Linde F, Nieto-Diaz A. Central pontine myelinolysis during pregnancy: pathogenesis, diagnosis and management. J Obstet Gynaecol 2017;37(3):273-9. PMID 27922286
163: Saroja AO, Naik KR, Mali RV, Kunam SR. “Wine Glass” sign in recurrent postpartum hypernatremic osmotic cerebral demyelination. Ann Indian Acad Neurol 2013;16(1):106-10.** PMID 23661977
164: Saunders I, Williams DM, Ruslan AM, Min T. Osmotic demyelination syndrome following slow correction of hyponatraemia. BMJ Case Rep 2021;14(8):e241407. PMID 34373247
165: Scalisi J, Balau B, Deneyer L, Bouchat J, Gilloteaux J, Nicaise C. Blood-brain barrier permeability towards small and large tracers in a mouse model of osmotic demyelination syndrome. Neurosci Lett 2021;746:135665. PMID 33497716
166: Shah MK, Mandayam S, Adrogué HJ. Osmotic demyelination unrelated to hyponatremia. Am J Kidney Dis 2018;71(3):436-40. PMID 29277507
167: Shrestha S, Kharel S, Gautam S, et al. Pontine and bilateral cerebellar lesion in osmotic demyelination syndrome associated with uncontrolled type II diabetes mellitus: a case report. Ann Med Surg (Lond) 2023;85(3):477-80. PMID 36923777
168: Silva FA, Rueda-Clausen CF, Ramírez F. Mielinólisis osmótica extrapóntica [Extrapontine osmotic myelinolysis]. Biomedica 2005;25(2):167-9. PMID 16022370
169: Silver SM, Schroeder BM, Sterns RH, Rojiani AM. Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats. J Neuropathol Exp Neurol 2006;65:37-44. PMID 16410747
170: Sindhu DM, Holla VV, Prasad S, et al. The spectrum of movement disorders in cases with osmotic demyelination syndrome. Mov Disord Clin Pract 2021;8(6):875-84.** PMID 34405095
171: Singh TD, Fugate JE, Rabinstein AA. Central pontine and extrapontine myelinolysis: a systematic review. Eur J Neurol 2014;21(12):1443-50.** PMID 25220878
172: Siranart N, Nakaphan P, Viarasilpa V, Anukoolwittaya P, Hemachudha P. Hand knob sign in osmotic demyelinating syndrome. BMC Neurol 2024;24(1):83. PMID 38429668
173: Sivaswamy L, Karia S. Extrapontine myelinolysis in a 4 year old with diabetic ketoacidosis. Eur J Paediatr Neurol 2007;11(6):389-93. PMID 17425961
174: Sood L, Sterns RH, Hix JK, Silver SM, Chen L. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia. Am J Kidney Dis 2013;61(4):571-8. PMID 23266328
175: Soupart A, Ngassa M, Decaux G. Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia. Clin Nephrol 1999;51(6):383-6. PMID 10404700
176: Soupart A, Penninckx R, Namias B, Stenuit A, Perier O, Decaux G. Brain myelinolysis following hypernatremia in rats. J Neuropathol Exp Neurol 1996a;55(1):106-13. PMID 8558165
177: Soupart A, Penninckx R, Stenuit A, Perier O, Decaux G. Reinduction of hyponatremia improves survival in rats with myelinolysis-related neurologic symptoms. J Neuropathol Exp Neurol 1996b;55(5):594-601. PMID 8627349
178: Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med 2014;40(3):320-31. Erratum in: Intensive Care Med 2014a;40(6):924.** PMID 24562549
179: Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 2014;170(3):G1-47. Erratum in: Eur J Endocrinol 2014b;171(1):X1.** PMID 24569125
180: Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant 2014;29 Suppl 2:i1-i39. Erratum in: Nephrol Dial Transplant 2014c;40(6):924.** PMID 24569496
181: Sterns RH, Hix JK, Silver SM. Management of hyponatremia in the ICU. Chest 2013;144(2):672-9. PMID 23918113
182: Sterns RH, Riggs JE, Schochet SS Jr. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 1986;314(24):1535-42.** PMID 3713747
183: Sugimura Y, Murase T, Takefuji S, et al. Protective effect of dexamethasone on osmotic-induced demyelination in rats. Exp Neurol 2005;192(1):178-83. PMID 15698632
184: Sumi H, Imai N, Shibagaki Y. Incidence and risk factors of overcorrection in patients presenting with severe hyponatremia to the emergency department. Clin Exp Nephrol 2022;26(11):1086-91.** PMID 35870090
185: Sun WP, Wang YD, Gao S, Wang YF, Li DW. A rare presentation of central pontine myelinolysis secondary to hyperglycaemia. BMC Endocr Disord 2023;23(1):106. PMID 37165361
186: Suri V, Jasuja S, Suri N, Saini R, Naga MK, Suri K. Postpartum hypernatremic encephalopathy with “wine glass sign” on magnetic resonance imaging. Apollo Med 2017;14(3):188-9.
187: Sutamnartpong P, Muengtaweepongsa S, Kulkantrakorn K. Wernicke's encephalopathy and central pontine myelinolysis in hyperemesis gravidarum. J Neurosci Rural Pract 2013;4(1):39-41. PMID 23546346
188: Suzuki H, Sugimura Y, Iwama S, et al. Minocycline prevents osmotic demyelination syndrome by inhibiting the activation of microglia. J Am Soc Nephrol 2010;21(12):2090-8. PMID 21030598
189: Takagi H, Sugimura Y, Suzuki H, et al. Minocycline prevents osmotic demyelination associated with aquaresis. Kidney Int 2014;86(5):954-64. PMID 24759153
190: Takefuji S, Murase T, Sugimura Y, et al. Role of microglia in the pathogenesis of osomotic-induced demyelination. Exp Neurol 2007;204:88-94. PMID 17126835
191: Tanaka Y, Matsuki M, Furukawa R, et al. Imaging of extrapontine myelinolysis preceding central pontine myelinolysis in a case of ornithine transcarbamylase deficiency with hyperammonaemia and hypokalaemia. BMJ Neurol Open 2022;4(2):e000354. PMID 36437853
192: Tandukar S, Sterns RH, Rondon-Berrios H. Osmotic demyelination syndrome following correction of hyponatremia by ≤10 mEq/L per day. Kidney360 2021;2(9):1415-23. PMID 35373113
193: Thompson DS, Hutton JT, Stears JC, Sung JH, Norenberg M. Computerized tomography in the diagnosis of central and extrapontine myelinolysis. Arch Neurol 1981;38(4):243-6. PMID 7213148
194: Thurston JH, Hauhart RE, Nelson JS. Adaptive decreases in amino acids (taurine in particular), creatine, and electrolytes prevent cerebral edema in chronically hyponatremic mice: rapid correction (experimental model of central pontine myelinolysis) causes dehydration and shrinkage of brain. Metab Brain Dis. 1987;2(4):223-41. PMID 3505340
195: Tobiume M, Iha N, Miyahira A, Kariya S. A 44-year-old alcohol-dependent man who recovered from central pontine myelinolysis with supportive physical therapy. Am J Case Rep 2022;23:e937389. PMID 36081331
196: Turnbull J, Lumsden D, Siddiqui A, Lin JP, Lim M. Osmotic demyelination syndrome associated with hypophosphataemia: 2 cases and a review of literature. Acta Paediatr 2013;102(4):e164-8. PMID 23278861
197: Vu T, Wong R, Hamblin PS, Zajac J, Grossmann M. Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes. Hosp Pract (1995) 2009;37(1):128-36. PMID 20877181
198: Vyas S, Saini AG, Kaur A, et al. Neuroimaging spectrum of severe hypernatremia in infants with neurological manifestations. Neuropediatrics 2021;52(4):316-25. PMID 34192787
199: Wendland EM, Kaplan AA. A proposed approach to the dialysis prescription in severely hyponatremic patients with end-stage renal disease. Semin Dial 2012;25(1):82-5. PMID 21906168
200: Werder M, Ruppert RK, Bajc O, Truniger B. Zentrale pontine myelinolyse und Schwartz-Bartter-Syndrome [Central pontine myelinolysis and Schwartz-Bartter syndrome]. Schweiz Med Wochenschr 1982;112(21):765-9. PMID 7100873
201: Wijayabandara M, Appuhamy S, Weerathunga P, Chang T. Effective treatment of osmotic demyelination syndrome with plasmapheresis: a case report and review of the literature. J Med Case Rep 2021;15(1):6. PMID 33430956
202: Wijesundara D, Senanayake B. Plasmapheresis for extrapontine myelinolysis: a case series and a literature review. Case Rep Neurol 2022;14(1):72-81. PMID 35350290
203: Wright DG, Laureno R, Victor M. Pontine and extrapontine myelinolysis. Brain 1979;102(2):361-85.** PMID 455045
204: Yadav A, Sherpali A, Bashyal B, Kala Kharel K, Parajuli N. Osmotic demyelination syndrome with transient diabetes insipidus in postpartum female: a case report. Ann Med Surg (Lond) 2023;85(8):4096-9. PMID 37554876
205: Yadav RK, Das CJ, Bagchi S, Agarwal S. Asymptomatic pontine and extra-pontine lesions in a patient with end-stage renal disease. Saudi J Kidney Dis Transpl 2016;27(2):395-7. PMID 26997398
206: Yadav SK, Ojha R, Parajuli N, et al. Occurrence of osmotic demyelination syndrome in diabetes mellitus: A case report and literature review of various etiologies for osmotic demyelination syndrome. SAGE Open Med Case Rep 2022;10:2050313X221135595. PMID 36337162
207: Yamada H, Takano K, Ayuzawa N, Seki G, Fujita T. Relowering of serum Na for osmotic demyelinating syndrome. Case Rep Neurol Med 2012;2012:704639. PMID 22937357
208: Yang H, Yoon S, Kim EJ, et al. Risk factors for overcorrection of severe hyponatremia: a post hoc analysis of the SALSA trial. Kidney Res Clin Pract 2022;41(3):298-309.** PMID 35286796
209: Yokota Y, Oka K, Yasuda M, Otsuka F. Osmotic demyelination syndrome triggered by pituitary apoplexy. Intern Med 2020;59(6):869-70. PMID 31761886

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Douglas J Lanska MD MS MSPH

Dr. Lanska of the University of Wisconsin School of Medicine and Public Health and the Medical College of Wisconsin has no relevant financial relationships to disclose.
See Profile

Former Authors

Zachary N London MD
Jack E Riggs MD
Nicholas J Beimer MD

Patient Profile

Age range of presentation: 1 month to 65+ years
Sex preponderance: male=female
Heredity: none
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-10: Other specified demyelinating diseases of central nervous system: G37.8
ICD-11: Multiple sclerosis or other white matter disorders, unspecified: 8A4Z

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Osmotic demyelination syndromes

Associated Disorders

Alcoholism
Extrapontine myelinolysis
Hyperosmolar hyperglycemic state
Hypokalemia
Malnutrition
- Osmotic myelinolysis

Differential Diagnosis

other coexistent disorders
metabolic encephalopathy
hypoxic encephalopathy
additional neurologic dysfunction
other abnormalities on MRI

Also Relevant

Alcohol abuse and its neurologic complications

Clinical Categories

General Neurology

Patient Handouts

Central pontine myelinolysis

Osmotic demyelination syndromes …

Osmotic demyelination syndromes

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Special considerations

Pregnancy

Liver disease

Children

Media

References

Contributors

Author

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Neurogenetics and genetic and genomic testing

Acute traumatic spinal cord injury

Tumors of the skull base

Toxic and nutritional deficiency optic neuropathies

Third nerve palsy

Nystagmus

Brain death/death by neurologic criteria

Outpatient rehabilitation of chronic neurologic conditions

Osmotic demyelination syndromes

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Diagnostic workup

Management

Special considerations

Pregnancy

Liver disease

Children

Media

References

Contributors

Author

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Neurogenetics and genetic and genomic testing

Acute traumatic spinal cord injury

Tumors of the skull base

Toxic and nutritional deficiency optic neuropathies

Third nerve palsy

Nystagmus

Brain death/death by neurologic criteria

Outpatient rehabilitation of chronic neurologic conditions

This is an article preview.
Start a Free Account
to access the full version.